<html class="gs_el_sm gs_pfcs"><head><title>‪Joe M. O'Sullivan‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=ojU5mu4AAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Radiation Oncology., Queen's University Belfast‬ - ‪‪Cited by 17,845‬‬ - ‪Prostate cancer‬ - ‪Radionuclide therapy‬ - ‪Radiotherapy‬ - ‪Cancer‬"><meta property="og:description" content="‪Professor of Radiation Oncology., Queen's University Belfast‬ - ‪‪Cited by 17,845‬‬ - ‪Prostate cancer‬ - ‪Radionuclide therapy‬ - ‪Radiotherapy‬ - ‪Cancer‬"><meta property="og:title" content="Joe M. O'Sullivan"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=ojU5mu4AAAAJ&amp;citpid=3"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"SZxAYYkPifCaAYewkLAJ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=ojU5mu4AAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUHtye_5qSA2YZUsixsq0p1ILttFPcmv"><input type="hidden" name="user" value="ojU5mu4AAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">17845</td><td class="gsc_rsb_std">13685</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">54</td><td class="gsc_rsb_std">42</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">147</td><td class="gsc_rsb_std">129</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:550px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:504px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">2900</div><div class="gsc_g_xtl" style="top:73px;">1450</div><div class="gsc_g_xtl" style="top:113px;">725</div><div class="gsc_g_xtl" style="top:33px;">2175</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:158px;height:2px;z-index:15"><span class="gsc_g_al">48</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:158px;height:2px;z-index:14"><span class="gsc_g_al">43</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:158px;height:2px;z-index:13"><span class="gsc_g_al">45</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:154px;height:6px;z-index:12"><span class="gsc_g_al">110</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:150px;height:10px;z-index:11"><span class="gsc_g_al">195</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:134px;height:26px;z-index:10"><span class="gsc_g_al">476</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:122px;height:38px;z-index:9"><span class="gsc_g_al">702</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:108px;height:52px;z-index:8"><span class="gsc_g_al">951</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:92px;height:68px;z-index:7"><span class="gsc_g_al">1238</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:78px;height:82px;z-index:6"><span class="gsc_g_al">1488</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:50px;height:110px;z-index:5"><span class="gsc_g_al">2007</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:29px;height:131px;z-index:4"><span class="gsc_g_al">2392</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:24px;height:136px;z-index:3"><span class="gsc_g_al">2466</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:5px;height:155px;z-index:2"><span class="gsc_g_al">2815</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:34px;height:126px;z-index:1"><span class="gsc_g_al">2301</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=ojU5mu4AAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dojU5mu4AAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>63 articles</span></div><div class="gsc_rsb_m_na"><div>16 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:20%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:85px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:53pt;}}</style><img alt="Joe M. O'Sullivan" sizes="print 80px,128px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ojU5mu4AAAAJ&amp;citpid=3" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ojU5mu4AAAAJ&amp;citpid=3 128w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=ojU5mu4AAAAJ&amp;citpid=3 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Joe M. O'Sullivan</div><div class="gsc_prf_il">Professor of Radiation Oncology., <a href="/citations?view_op=view_org&amp;hl=en&amp;org=2175268696339219833" class="gsc_prf_ila">Queen's University Belfast</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at qub.ac.uk - <a href="https://www.researchgate.net/profile/Joe_OSullivan/" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:prostate_cancer" class="gsc_prf_inta gs_ibl">Prostate cancer</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:radionuclide_therapy" class="gsc_prf_inta gs_ibl">Radionuclide therapy</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:radiotherapy" class="gsc_prf_inta gs_ibl">Radiotherapy</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cancer" class="gsc_prf_inta gs_ibl">Cancer</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUHtye_5qSA2YZUsixsq0p1ILttFPcmv"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=ojU5mu4AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Alpha emitter radium-223 and survival in metastatic prostate cancer</a><div class="gs_gray">C Parker, S Nilsson, D Heinrich, SI Helle, JM O'sullivan, SD Fosså, ...</div><div class="gs_gray">New England Journal of Medicine 369 (3), 213-223<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15722760994772151186" class="gsc_a_ac gs_ibl">2739</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:MLfJN-KU85MC" class="gsc_a_at">Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage&nbsp;…</a><div class="gs_gray">ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...</div><div class="gs_gray">The Lancet 387 (10024), 1163-1177<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15307335425929504942" class="gsc_a_ac gs_ibl">1449</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Abiraterone for prostate cancer not previously treated with hormone therapy</a><div class="gs_gray">ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...</div><div class="gs_gray">New England Journal of Medicine 377 (4), 338-351<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3710298957277874758" class="gsc_a_ac gs_ibl">1111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Gold nanoparticles as novel agents for cancer therapy</a><div class="gs_gray">S Jain, DG Hirst, JM O'sullivan</div><div class="gs_gray">The British journal of radiology 85 (1010), 101-113<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9417182885349511700" class="gsc_a_ac gs_ibl">967</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial</a><div class="gs_gray">D Dearnaley, I Syndikus, H Mossop, V Khoo, A Birtle, D Bloomfield, ...</div><div class="gs_gray">The Lancet Oncology 17 (8), 1047-1060<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9625067733763133112" class="gsc_a_ac gs_ibl">744</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Radiation-induced bystander signalling in cancer therapy</a><div class="gs_gray">KM Prise, JM O'sullivan</div><div class="gs_gray">Nature Reviews Cancer 9 (5), 351-360<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12943154159642436209" class="gsc_a_ac gs_ibl">729</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:FiytvqdAVhgC" class="gsc_a_at">Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial</a><div class="gs_gray">CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ...</div><div class="gs_gray">The Lancet 392 (10162), 2353-2366<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3340315107527973326" class="gsc_a_ac gs_ibl">552</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017</a><div class="gs_gray">S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...</div><div class="gs_gray">European urology 73 (2), 178-211<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10883288468354650412,12173529554396320554" class="gsc_a_ac gs_ibl">546</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="ojU5mu4AAAAJ:YsrPvlHIBpEC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies</a><div class="gs_gray">S Jain, JA Coulter, AR Hounsell, KT Butterworth, SJ McMahon, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 79 (2), 531-539<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6055856041459163522" class="gsc_a_ac gs_ibl">457</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind&nbsp;…</a><div class="gs_gray">O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ...</div><div class="gs_gray">The Lancet Oncology 15 (7), 738-746<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15804587638008149331" class="gsc_a_ac gs_ibl">441</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles</a><div class="gs_gray">SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ...</div><div class="gs_gray">Scientific reports 1 (1), 1-10<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15064404201759056954,14863848599610924994" class="gsc_a_ac gs_ibl">375</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:_Ybze24A_UAC" class="gsc_a_at">Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a&nbsp;…</a><div class="gs_gray">P Hoskin, O Sartor, JM O'Sullivan, DC Johannessen, SI Helle, J Logue, ...</div><div class="gs_gray">The Lancet Oncology 15 (12), 1397-1406<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16080705152039016674" class="gsc_a_ac gs_ibl">348</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours</a><div class="gs_gray">JM O’sullivan, RA Huddart, AR Norman, J Nicholls, DP Dearnaley, ...</div><div class="gs_gray">Annals of Oncology 14 (1), 91-96<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17650547793884510079" class="gsc_a_ac gs_ibl">332</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial</a><div class="gs_gray">F Saad, J Carles, S Gillessen, A Heidenreich, D Heinrich, J Gratt, J Lévy, ...</div><div class="gs_gray">The Lancet Oncology 17 (9), 1306-1316<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6991959541958717498" class="gsc_a_ac gs_ibl">245</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy</a><div class="gs_gray">B Nugent, S Lewis, JM O'Sullivan</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9575001513348047865,17241603957276537051" class="gsc_a_ac gs_ibl">222</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:UebtZRa9Y70C" class="gsc_a_at">Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy</a><div class="gs_gray">SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ...</div><div class="gs_gray">Radiotherapy and Oncology 100 (3), 412-416<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12712681045040113458" class="gsc_a_ac gs_ibl">198</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:aqlVkmm33-oC" class="gsc_a_at">Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles</a><div class="gs_gray">JA Coulter, S Jain, KT Butterworth, LE Taggart, GR Dickson, SJ McMahon, ...</div><div class="gs_gray">International journal of nanomedicine 7, 2673<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11842902112077190750" class="gsc_a_ac gs_ibl">184</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Docetaxel and/or zoledronic acid for hormone-naïve prostate cancer: First survival results from STAMPEDE</a><div class="gs_gray">N James, M Mason</div><div class="gs_gray">J Clin Oncol 33 (33), 5001<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16513287439208553323" class="gsc_a_ac gs_ibl">170</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:0EnyYjriUFMC" class="gsc_a_at">A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer</a><div class="gs_gray">CC Parker, S Pascoe, A Chodacki, JM O'Sullivan, JR Germá, ...</div><div class="gs_gray">European urology 63 (2), 189-197<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5086829238807448168" class="gsc_a_ac gs_ibl">168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;citation_for_view=ojU5mu4AAAAJ:6yz0xqPARnAC" class="gsc_a_at">Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol</a><div class="gs_gray">MR Sydes, MR Spears, MD Mason, NW Clarke, DP Dearnaley, ...</div><div class="gs_gray">Annals of Oncology 29 (5), 1235-1248<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15206380328980291592" class="gsc_a_ac gs_ibl">161</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:qjMakFHDy7sC" class="gsc_a_at">Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation</a><div class="gs_gray">A Seaton, P Scullin, PJ Maxwell, C Wilson, J Pettigrew, R Gallagher, ...</div><div class="gs_gray">Carcinogenesis 29 (6), 1148-1156<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5740879588824199713" class="gsc_a_ac gs_ibl">161</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">STAMPEDE investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive&nbsp;…</a><div class="gs_gray">ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...</div><div class="gs_gray">Lancet 387 (10024), 1163-77<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14520558199701220061" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Overall survival benefit of radium-223 chloride (Alpharadin) in the treatment of patients with symptomatic bone metastases in castration-resistant prostate cancer (CRPC): a&nbsp;…</a><div class="gs_gray">C Parker, D Heinrich, JM OSullivan, S Fossa, A Chodacki, T Demkow, ...</div><div class="gs_gray">European Journal of Cancer 47 (2), 3<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10184880994967011471" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:BzfGm06jWhQC" class="gsc_a_at">Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial</a><div class="gs_gray">ND James, MR Spears, NW Clarke, DP Dearnaley, MD Mason, CC Parker, ...</div><div class="gs_gray">JAMA oncology 2 (3), 348-357<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10306022109388992196" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:kWvqk_afx_IC" class="gsc_a_at">Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial</a><div class="gs_gray">NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...</div><div class="gs_gray">Annals of oncology 30 (12), 1992-2003<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4518829249138433896" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of&nbsp;…</a><div class="gs_gray">A Wilkins, H Mossop, I Syndikus, V Khoo, D Bloomfield, C Parker, J Logue, ...</div><div class="gs_gray">The Lancet Oncology 16 (16), 1605-1616<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14066500701850351061" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:ufrVoPGSRksC" class="gsc_a_at">The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis</a><div class="gs_gray">F Haseen, LJ Murray, CR Cardwell, JM O’Sullivan, MM Cantwell</div><div class="gs_gray">Journal of cancer survivorship 4 (2), 128-139<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17978567607594654989" class="gsc_a_ac gs_ibl">124</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:HDshCWvjkbEC" class="gsc_a_at">Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis</a><div class="gs_gray">CM McCourt, DG McArt, K Mills, MA Catherwood, P Maxwell, DJ Waugh, ...</div><div class="gs_gray">PLoS One 8 (7), e69604<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13607617238180307240" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:WZBGuue-350C" class="gsc_a_at">Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study</a><div class="gs_gray">S Nilsson, P Cislo, O Sartor, NJ Vogelzang, RE Coleman, JM O'Sullivan, ...</div><div class="gs_gray">Annals of Oncology 27 (5), 868-874<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1384023526445741922" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Updated analysis of the phase III, double-blind, randomized, multinational study of radium-223 chloride in castration-resistant prostate cancer (CRPC) patients with bone&nbsp;…</a><div class="gs_gray">C Parker, S Nilsson, D Heinrich, JM O'Sullivan, SD Fossa, A Chodacki, ...</div><div class="gs_gray">J Clin Oncol 30 (Suppl), LBA4512<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5310787841676673602" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor&nbsp;…</a><div class="gs_gray">C Wilson, C Purcell, A Seaton, O Oladipo, PJ Maxwell, JM O'Sullivan, ...</div><div class="gs_gray">Journal of Pharmacology and Experimental Therapeutics 327 (3), 746-759<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2509613795609805598" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:5nxA0vEk-isC" class="gsc_a_at">Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial</a><div class="gs_gray">ND James, MR Sydes, MD Mason, NW Clarke, J Anderson, DP Dearnaley, ...</div><div class="gs_gray">The lancet oncology 13 (5), 549-558<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=449211900359399298" class="gsc_a_ac gs_ibl">113</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:tzM49s52ZIMC" class="gsc_a_at">Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha-pharmaceutical: Results from a phase III randomized trial (ALSYMPCA) in patients with&nbsp;…</a><div class="gs_gray">C Parker, D Heinrich, JM O'Sullivan, SD Fossa, A Chodacki, T Demkow, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (5_suppl), 8-8<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9820530954574418895" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods</a><div class="gs_gray">GG Hanna, AR Hounsell, JM O’Sullivan</div><div class="gs_gray">Clinical oncology 22 (7), 515-525<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11543765912430886259" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:4vMrXwiscB8C" class="gsc_a_at">An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223</a><div class="gs_gray">O Sartor, RE Coleman, S Nilsson, D Heinrich, SI Helle, JM O’Sullivan, ...</div><div class="gs_gray">Annals of Oncology 28 (5), 1090-1097<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5646159866735411498" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:roLk4NBRz8UC" class="gsc_a_at">Out-of-field cell survival following exposure to intensity-modulated radiation fields</a><div class="gs_gray">KT Butterworth, CK McGarry, C Trainor, JM O’Sullivan, AR Hounsell, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 79 (5), 1516-1522<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5487472961245271961" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review</a><div class="gs_gray">F Haseen, MM Cantwell, JM O'sullivan, LJ Murray</div><div class="gs_gray">Prostate cancer and prostatic diseases 12 (4), 325-332<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10657281649057558820" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Bone-targeting radiopharmaceuticals including radium-223</a><div class="gs_gray">D Brady, CC Parker, JM O’Sullivan</div><div class="gs_gray">The Cancer Journal 19 (1), 71-78<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5433772417826443319" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions</a><div class="gs_gray">S Jain, JA Coulter, KT Butterworth, AR Hounsell, SJ McMahon, ...</div><div class="gs_gray">Radiotherapy and Oncology 110 (2), 342-347<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=153632257707787540" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Three-year safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases from phase 3 randomized alpharadin in&nbsp;…</a><div class="gs_gray">CC Parker, RE Coleman, O Sartor, NJ Vogelzang, D Bottomley, ...</div><div class="gs_gray">European urology 73 (3), 427-435<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13410661847861175291" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:86PQX7AUzd4C" class="gsc_a_at">Hematologic safety of radium-223 dichloride: baseline prognostic factors associated with myelosuppression in the ALSYMPCA trial</a><div class="gs_gray">NJ Vogelzang, RE Coleman, JM Michalski, S Nilsson, JM O'Sullivan, ...</div><div class="gs_gray">Clinical genitourinary cancer 15 (1), 42-52. e8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13895729165329649418" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital</a><div class="gs_gray">JM O'Sullivan, AR Norman, GJ Cook, C Fisher, DP Dearnaley</div><div class="gs_gray">BJU international 92 (7), 685-689<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5418648913133445488" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial</a><div class="gs_gray">CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ...</div><div class="gs_gray">The Lancet 396 (10260), 1413-1421<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1747661576974287700" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:hCrLmN-GePgC" class="gsc_a_at">Efficacy and safety of radium-223 dichloride in symptomatic castration-resistant prostate cancer patients with or without baseline opioid use from the phase 3 ALSYMPCA trial</a><div class="gs_gray">C Parker, SE Finkelstein, JM Michalski, JM O'Sullivan, Ø Bruland, ...</div><div class="gs_gray">European urology 70 (5), 875-883<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15668079169514992835" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Consensus on molecular imaging and theranostics in prostate cancer</a><div class="gs_gray">S Fanti, S Minozzi, G Antoch, I Banks, A Briganti, I Carrio, A Chiti, N Clarke, ...</div><div class="gs_gray">The lancet oncology 19 (12), e696-e708<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4441570845404305625" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Fiducial marker guided prostate radiotherapy: a review</a><div class="gs_gray">AGM O'Neill, S Jain, AR Hounsell, JM O'Sullivan</div><div class="gs_gray">The British journal of radiology 89 (1068), 20160296<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16275247617182365559" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:YOwf2qJgpHMC" class="gsc_a_at">The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria</a><div class="gs_gray">F Abogunrin, HF O'Kane, MW Ruddock, M Stevenson, CN Reid, ...</div><div class="gs_gray">Cancer 118 (10), 2641-2650<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7915197207517549001" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:hqOjcs7Dif8C" class="gsc_a_at">18f-fdg pet-ct simulation for non–small-cell lung cancer: effect in patients already staged by pet-ct</a><div class="gs_gray">GG Hanna, J McAleese, KJ Carson, DP Stewart, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 77 (1), 24-30<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18052927221354890909" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:L8Ckcad2t8MC" class="gsc_a_at">A kinetic-based model of radiation-induced intercellular signalling</a><div class="gs_gray">SJ McMahon, KT Butterworth, C Trainor, CK McGarry, JM O’Sullivan, ...</div><div class="gs_gray">PloS one 8 (1), e54526<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6234269436198383341" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:4DMP91E08xMC" class="gsc_a_at">Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer</a><div class="gs_gray">S Hynds, CK McGarry, DM Mitchell, S Early, L Shum, DP Stewart, ...</div><div class="gs_gray">The British journal of radiology 84 (1005), 813-818<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15705075970390003633" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Clinical outcomes and survival following treatment of metastatic castrate-refractory prostate cancer with docetaxel alone or with strontium-89, zoledronic acid, or both: the&nbsp;…</a><div class="gs_gray">ND James, SJ Pirrie, AM Pope, D Barton, L Andronis, I Goranitis, S Collins, ...</div><div class="gs_gray">JAMA oncology 2 (4), 493-499<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12179408984018465131" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:a0OBvERweLwC" class="gsc_a_at">Motion management for radical radiotherapy in non-small cell lung cancer</a><div class="gs_gray">AJ Cole, GG Hanna, S Jain, JM O'Sullivan</div><div class="gs_gray">Clinical oncology 26 (2), 67-80<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5716087347686164259" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Bystander signalling: exploring clinical relevance through new approaches and new models</a><div class="gs_gray">KT Butterworth, SJ McMahon, AR Hounsell, JM O'sullivan, KM Prise</div><div class="gs_gray">Clinical Oncology 25 (10), 586-592<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10698238948509868886" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:hC7cP41nSMkC" class="gsc_a_at">Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor–targeted therapy</a><div class="gs_gray">C McCourt, P Maxwell, R Mazzucchelli, R Montironi, M Scarpelli, ...</div><div class="gs_gray">Clinical cancer research 18 (14), 3822-3833<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8312712858259207762" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:WF5omc3nYNoC" class="gsc_a_at">High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone</a><div class="gs_gray">JM O'Sullivan, VR McCready, G Flux, AR Norman, FM Buffa, S Chittenden, ...</div><div class="gs_gray">British journal of cancer 86 (11), 1715-1720<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13113567100974945350" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:nrtMV_XWKgEC" class="gsc_a_at">A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate&nbsp;…</a><div class="gs_gray">RF O’Neill, F Haseen, LJ Murray, JM O’Sullivan, MM Cantwell</div><div class="gs_gray">Journal of Cancer Survivorship 9 (3), 431-440<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5970906926600148035" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:_kc_bZDykSQC" class="gsc_a_at">DNA damage responses following exposure to modulated radiation fields</a><div class="gs_gray">C Trainor, KT Butterworth, CK McGarry, SJ McMahon, JM O’Sullivan, ...</div><div class="gs_gray">Public Library of Science 7 (8), e43326<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11542419677290036452" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:YsMSGLbcyi4C" class="gsc_a_at">A review of the efficacy of bone scanning in prostate and breast cancer</a><div class="gs_gray">JM O'sullivan, GJR Cook</div><div class="gs_gray">The Quarterly Journal of Nuclear Medicine and Molecular Imaging 46 (2), 152<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14168650196743409009" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:YFjsv_pBGBYC" class="gsc_a_at">What is the role of the bystander response in radionuclide therapies?</a><div class="gs_gray">D Brady, JM O'Sullivan, KM Prise</div><div class="gs_gray">Frontiers in oncology 3, 215<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9350912067437283184" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro</a><div class="gs_gray">M Prencipe, P Fitzpatrick, S Gorman, M Mosetto, R Klinger, F Furlong, ...</div><div class="gs_gray">British journal of cancer 101 (11), 1900-1908<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7650032184409899540" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Se3iqnhoufwC" class="gsc_a_at">Radium-223 chloride impact on skeletal-related events in patients with castration-resistant prostate cancer (CRPC) with bone metastases: A phase III randomized trial (ALSYMPCA).</a><div class="gs_gray">AO Sartor, D Heinrich, SI Helle, JM O'Sullivan, SD Fossa, A Chodacki, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (5_suppl), 9-9<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3317584257309594698" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:mVmsd5A6BfQC" class="gsc_a_at">A computational model of cellular response to modulated radiation fields</a><div class="gs_gray">SJ McMahon, KT Butterworth, CK McGarry, C Trainor, JM O’Sullivan, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 84 (1), 250-256<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5959109728166583486" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:IWHjjKOFINEC" class="gsc_a_at">Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics</a><div class="gs_gray">CK McGarry, CD Chinneck, MM O'Toole, JM O'Sullivan, KM Prise, ...</div><div class="gs_gray">Medical physics 38 (4), 2027-2034<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1634241029588727491" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Adding celecoxib with or without zoledronic acid for hormone-naïve prostate cancer: long-term survival results from an adaptive, multiarm, multistage, platform, randomized&nbsp;…</a><div class="gs_gray">MD Mason, NW Clarke, ND James, DP Dearnaley, MR Spears, ...</div><div class="gs_gray">Journal of clinical oncology 35 (14), 1530<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16912537047965364093" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:fEOibwPWpKIC" class="gsc_a_at">Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts</a><div class="gs_gray">G Comito, CP Segura, ML Taddei, M Lanciotti, S Serni, A Morandi, ...</div><div class="gs_gray">Oncotarget 8 (1), 118<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1661174363921029029" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:SdhP9T11ey4C" class="gsc_a_at">Beta-blocker usage and prostate cancer survival: a nested case–control study in the UK Clinical Practice Research Datalink cohort</a><div class="gs_gray">CR Cardwell, HG Coleman, LJ Murray, JM O'Sullivan, DG Powe</div><div class="gs_gray">Cancer epidemiology 38 (3), 279-285<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10215280993898313459" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Dose, dose-rate and field size effects on cell survival following exposure to non-uniform radiation fields</a><div class="gs_gray">KT Butterworth, CK McGarry, C Trainor, SJ McMahon, JM O’Sullivan, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 57 (10), 3197<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14685217083927164861" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:HtS1dXgVpQUC" class="gsc_a_at">The role of therapeutic layering in optimizing treatment for patients with castration-resistant prostate cancer (Prostate Cancer Radiographic Assessments for Detection of&nbsp;…</a><div class="gs_gray">ED Crawford, DP Petrylak, N Shore, F Saad, SF Slovin, NJ Vogelzang, ...</div><div class="gs_gray">Urology 104, 150-159<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=760552708869771781" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Effect of radium-223 dichloride (Ra-223) on hospitalisation: an analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial</a><div class="gs_gray">C Parker, L Zhan, P Cislo, J Reuning-Scherer, NJ Vogelzang, S Nilsson, ...</div><div class="gs_gray">European Journal of Cancer 71, 1-6<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15179585733660032043" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer</a><div class="gs_gray">C Wilson, P Scullin, J Worthington, A Seaton, P Maxwell, D O'Rourke, ...</div><div class="gs_gray">British journal of cancer 99 (12), 2054-2064<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10232253862741176388" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:U_HPUtbDl20C" class="gsc_a_at">Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia: INSPIRE</a><div class="gs_gray">AS Cerdeira, J O’Sullivan, EO Ohuma, D Harrington, P Szafranski, ...</div><div class="gs_gray">Hypertension 74 (4), 983-990<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1659255770242730827" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Cell survival responses after exposure to modulated radiation fields</a><div class="gs_gray">C Trainor, KT Butterworth, CK McGarry, F Liberante, JM O'Sullivan, ...</div><div class="gs_gray">Radiation research 177 (1), 44-51<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17418975752509445726" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:R3hNpaxXUhUC" class="gsc_a_at">A phase I study of combined docetaxel and repeated high activity 186 Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)</a><div class="gs_gray">JM van Dodewaard-de Jong, JMH de Klerk, HJ Bloemendal, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 38 (11), 1990-1998<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4651640229221037122" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:MXK_kJrjxJIC" class="gsc_a_at">A study of the biological effects of modulated 6 MV radiation fields</a><div class="gs_gray">KT Butterworth, CK McGarry, JM O'Sullivan, AR Hounsell, KM Prise</div><div class="gs_gray">Physics in Medicine &amp; Biology 55 (6), 1607<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5586844336362398964" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:DkZNVXde3BIC" class="gsc_a_at">Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets</a><div class="gs_gray">B Psaila, G Wang, A Rodriguez-Meira, R Li, EF Heuston, L Murphy, D Yee, ...</div><div class="gs_gray">Molecular cell 78 (3), 477-492. e8<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1907777676333935669,10864271288261225267" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:hMsQuOkrut0C" class="gsc_a_at">Final analysis of COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to&nbsp;…</a><div class="gs_gray">EM Basch, MC Scholz, JS De Bono, NJ Vogelzang, PL De Souza, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (7_suppl), 141-141<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6759311331381729623" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:tYavs44e6CUC" class="gsc_a_at">ICORG 05-03: Prospective randomized non-inferiority phase 3 trial comparing two radiation schedules in malignant spinal cord compression not proceeding with surgical decompression</a><div class="gs_gray">P Thirion, L O'Sullivan, A Clayton-Lea, C Small, O McArdle, P Kelly, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 90 (5), 1263-1264<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15305680650325536190" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:HIFyuExEbWQC" class="gsc_a_at">JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasms</a><div class="gs_gray">JM O'Sullivan, CN Harrison</div><div class="gs_gray">Molecular and cellular endocrinology 451, 71-79<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14289223091647750719" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP).</a><div class="gs_gray">F Saad, D Keizman, JM O'Sullivan, J Carles, M Wirth, S Gillessen, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 5082-5082<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13857329152010925659" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer</a><div class="gs_gray">LR Molife, A Omlin, RJ Jones, V Karavasilis, D Bloomfield, G Lumsden, ...</div><div class="gs_gray">Future oncology 10 (2), 219-231<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2208940506880418133" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink</a><div class="gs_gray">CR Cardwell, EM Flahavan, CM Hughes, HG Coleman, JM O’Sullivan, ...</div><div class="gs_gray">Cancer Causes &amp; Control 25 (1), 33-43<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13465177573348725999" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Advantages and limitations of navigation-based multicriteria optimization (MCO) for localized prostate cancer IMRT planning</a><div class="gs_gray">CK McGarry, R Bokrantz, JM O’Sullivan, AR Hounsell</div><div class="gs_gray">Medical Dosimetry 39 (3), 205-211<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17058465817879044554" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Br1UauaknNIC" class="gsc_a_at">Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program</a><div class="gs_gray">A Heidenreich, S Gillessen, D Heinrich, D Keizman, JM O’Sullivan, ...</div><div class="gs_gray">BMC cancer 19 (1), 1-10<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13393812746445062858" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Y5dfb0dijaUC" class="gsc_a_at">A longitudinal study of coping strategies in men receiving radiotherapy and neo‐adjuvant androgen deprivation for prostate cancer: a quantitative and qualitative study</a><div class="gs_gray">O McSorley, E McCaughan, G Prue, K Parahoo, B Bunting, J O'Sullivan</div><div class="gs_gray">Journal of advanced nursing 70 (3), 625-638<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18314543503486006930" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:mB3voiENLucC" class="gsc_a_at">Assessing the image quality of pelvic MR images acquired with a flat couch for radiotherapy treatment planning</a><div class="gs_gray">M McJury, A O'Neill, M Lawson, C McGrath, A Grey, W Page, ...</div><div class="gs_gray">The British journal of radiology 84 (1004), 750-755<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3301775191230169434" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:dhFuZR0502QC" class="gsc_a_at">Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated&nbsp;…</a><div class="gs_gray">CK McGarry, KT Butterworth, C Trainor, JM O'sullivan, KM Prise, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 56 (8), 2445<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16202451121031552584" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:4TOpqqG69KYC" class="gsc_a_at">Cranial nerve palsies in metastatic prostate cancer—results of base of skull radiotherapy</a><div class="gs_gray">JM O'Sullivan, AR Norman, H McNair, DP Dearnaley</div><div class="gs_gray">Radiotherapy and oncology 70 (1), 87-90<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5394399005301140354" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Active surveillance for favorable‐risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review</a><div class="gs_gray">E Ruane‐McAteer, S Porter, JM O'Sullivan, O Santin, G Prue</div><div class="gs_gray">Psycho‐oncology 26 (10), 1411-1421<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17390690060871495910" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Cabozantinib versus mitoxantrone-prednisone in symptomatic metastatic castration-resistant prostate cancer: a randomized phase 3 trial with a primary pain endpoint</a><div class="gs_gray">EM Basch, M Scholz, JS De Bono, N Vogelzang, P de Souza, G Marx, ...</div><div class="gs_gray">European urology 75 (6), 929-937<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14623046452421787774" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:5icHVeHT4IsC" class="gsc_a_at">Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy</a><div class="gs_gray">S Jain, CA Lyons, SM Walker, S McQuaid, SO Hynes, DM Mitchell, ...</div><div class="gs_gray">Annals of Oncology 29 (1), 215-222<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2778963224634482532" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:p__nRnzSRKYC" class="gsc_a_at">Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP&nbsp;…</a><div class="gs_gray">F Saad, J Carles, S Gillessen, D Heinrich, J Gratt, K Miller, S Nilsson, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 5034-5034<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6598511090690037570" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">The efficacy and safety of conventional and hypofractionated high-dose radiation therapy for prostate cancer in an elderly population: a subgroup analysis of the CHHiP trial</a><div class="gs_gray">JM Wilson, DP Dearnaley, I Syndikus, V Khoo, A Birtle, D Bloomfield, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 100 (5), 1179-1189<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6516830768705600881" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:TQgYirikUcIC" class="gsc_a_at">A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy</a><div class="gs_gray">F Haseen, LJ Murray, RF O'Neill, JM O'Sullivan, MM Cantwell</div><div class="gs_gray">Trials 11 (1), 1-10<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4010936096492709989" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:M3ejUd6NZC8C" class="gsc_a_at">A phase 2 study of high-activity 186 Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone</a><div class="gs_gray">JM O’Sullivan, AR Norman, VR McCready, G Flux, FM Buffa, B Johnson, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 33 (9), 1055-1061<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10243516054149018812" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:sszUF3NjhM4C" class="gsc_a_at">Advances in targeted alpha therapy for prostate cancer</a><div class="gs_gray">G De Vincentis, W Gerritsen, JE Gschwend, M Hacker, V Lewington, ...</div><div class="gs_gray">Annals of Oncology 30 (11), 1728-1739<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9089502816920135337" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).</a><div class="gs_gray">ND James, JS De Bono, MR Spears, N Clarke, MD Mason, DP Dearnaley, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (18_suppl), LBA5003-LBA5003<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17153540414836103678" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:5qfkUJPXOUwC" class="gsc_a_at">TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony&nbsp;…</a><div class="gs_gray">N James, S Pirrie, A Pope, D Barton, L Andronis, I Goranitis, S Collins, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7487871763560956902" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:P5F9QuxV20EC" class="gsc_a_at">Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy</a><div class="gs_gray">AJ Cole, JM O'Hare, SJ McMahon, CK McGarry, KT Butterworth, ...</div><div class="gs_gray">Clinical Oncology 26 (3), 142-150<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1607836588460428149" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:-f6ydRqryjwC" class="gsc_a_at">18F-fluorodeoxyglucose positron emission tomography/computed tomography–based radiotherapy target volume definition in non–small-cell lung cancer: Delineation by radiation&nbsp;…</a><div class="gs_gray">GG Hanna, KJ Carson, T Lynch, J McAleese, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 78 (4), 1040-1051<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5988587981121323736" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ojU5mu4AAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Heterogeneity in myeloproliferative neoplasms: Causes and consequences</a><div class="gs_gray">J O'Sullivan, AJ Mead</div><div class="gs_gray">Advances in biological regulation 71, 55-68<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17483747983336776279" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Recognizing symptom burden in advanced prostate cancer: a global patient and caregiver survey</a><div class="gs_gray">L Drudge-Coates, WK Oh, B Tombal, A Delacruz, B Tomlinson, AV Ripley, ...</div><div class="gs_gray">Clinical genitourinary cancer 16 (2), e411-e419<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4907196309299739269" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:olpn-zPbct0C" class="gsc_a_at">Implications of intercellular signaling for radiation therapy: a theoretical dose-planning study</a><div class="gs_gray">SJ McMahon, CK McGarry, KT Butterworth, JM O'Sullivan, AR Hounsell, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 87 (5), 1148-1154<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16834098394644093987" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:iH-uZ7U-co4C" class="gsc_a_at">In-vitro investigation of out-of-field cell survival following the delivery of conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy&nbsp;…</a><div class="gs_gray">CK McGarry, KT Butterworth, C Trainor, SJ McMahon, JM O'Sullivan, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 57 (20), 6635<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10448346225430122238" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Zph67rFs4hoC" class="gsc_a_at">Radium-223 chloride (Ra-223) impact on skeletal-related events (SREs) and ECOG performance status (PS) in patients with castration-resistant prostate cancer (CRPC) with bone&nbsp;…</a><div class="gs_gray">AO Sartor, D Heinrich, JM O’Sullivan, SD Fossa, A Chodacki, PJ Wiechno, ...</div><div class="gs_gray">J Clin Oncol 30 (Suppl)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13170084987490234554" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kNdYIx-mwKoC" class="gsc_a_at">A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186 Re-HEDP treatment of skeletal metastases from prostate cancer</a><div class="gs_gray">FM Buffa, GD Flux, MJ Guy, JM O'Sullivan, VR McCready, SJ Chittenden, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 30 (8), 1114-1124<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8368241399006330738" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:mWEH9CqjF64C" class="gsc_a_at">Targeted alpha therapy: Current clinical applications</a><div class="gs_gray">FDC Guerra Liberal, JM O'Sullivan, SJ McMahon, KM Prise</div><div class="gs_gray">Cancer biotherapy &amp; radiopharmaceuticals 35 (6), 404-417<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7173813549901644655" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Use of radionuclides in metastatic prostate cancer: pain relief and beyond</a><div class="gs_gray">S Vengalil, JM O'Sullivan, CC Parker</div><div class="gs_gray">Current opinion in supportive and palliative care 6 (3), 310-315<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13413555465826574046" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:8k81kl-MbHgC" class="gsc_a_at">Future directions for unsealed source radionuclide therapy for bone metastases</a><div class="gs_gray">VR McCready, JM O’Sullivan</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 29 (10), 1271-1275<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11268856702509521340" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:CB2v5VPnA5kC" class="gsc_a_at">The case against the European Medicines Agency’s change to the label for radium-223 for the treatment of metastatic castration-resistant prostate cancer</a><div class="gs_gray">CC Parker, B Tombal</div><div class="gs_gray">Eur. Urol 75, e51-e52<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15801382031726546531" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Myelofibrosis: clinicopathologic features, prognosis, and management</a><div class="gs_gray">JM O’Sullivan, CN Harrison</div><div class="gs_gray">Clin Adv Hematol Oncol 16 (2), 121-131<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16399643001185245071" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">The mediastinal staging accuracy of 18F-Fluorodeoxyglycose Positron Emission Tomography/Computed Tomography in non-small cell lung cancer with variable time intervals to surgery.</a><div class="gs_gray">K Booth, GG Hanna, N McGonigle, KG McManus, J McGuigan, ...</div><div class="gs_gray">The Ulster medical journal 82 (2), 75<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15571794523983316996" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:hkOj_22Ku90C" class="gsc_a_at">An analysis of geometric uncertainty calculations for prostate radiotherapy in clinical practice</a><div class="gs_gray">CK McGarry, VP Cosgrove, VAL Fleming, JM O'SULLIVAN, AR Hounsell</div><div class="gs_gray">The British journal of radiology 82 (974), 140-147<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9915560152895838944" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Disease characteristics and completion of treatment in patients with metastatic castration-resistant prostate cancer treated with radium-223 in an international early access&nbsp;…</a><div class="gs_gray">F Saad, S Gillessen, D Heinrich, D Keizman, JM O’Sullivan, S Nilsson, ...</div><div class="gs_gray">Clinical genitourinary cancer 17 (5), 348-355. e5<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17434697252145094263" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-95Q15plzcUC" class="gsc_a_at">Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study</a><div class="gs_gray">STARSurg Collaborative, ...</div><div class="gs_gray">BJS open 2 (6), 400-410<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16998877980780320896,1491048896745938902,7008615641784795813" class="gsc_a_ac gs_ibl">17</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="ojU5mu4AAAAJ:-95Q15plzcUC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:t7zJ5fGR-2UC" class="gsc_a_at"><sup>223</sup>Ra and other bone-targeting radiopharmaceuticals—the translation of radiation biology into clinical practice</a><div class="gs_gray">PG Turner, JM O'Sullivan</div><div class="gs_gray">The British journal of radiology 88 (1050), 20140752<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3437753604163595770" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:k_IJM867U9cC" class="gsc_a_at">Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries</a><div class="gs_gray">KT Butterworth, CK McGarry, B Clasie, A Carabe-Fernandez, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 57 (20), 6671<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6341098317987813194" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:XiSMed-E-HIC" class="gsc_a_at">An apparent recent decline in importations of dengue from Papua New Guinea into north Queensland</a><div class="gs_gray">JN Hanna, SA Ritchie</div><div class="gs_gray">Communicable diseases intelligence quarterly report 33 (1)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1425129322310939318" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Results of PAC203: a randomized phase 2 dose-finding study and determination of the recommended dose of pacritinib</a><div class="gs_gray">AT Gerds, MR Savona, BL Scott, M Talpaz, M Egyed, CN Harrison, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10257351875365575594" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:O0nohqN1r9EC" class="gsc_a_at">Association between peri‐operative angiotensin‐converting enzyme inhibitors and angiotensin‐2 receptor blockers and acute kidney injury in major elective non‐cardiac surgery: a&nbsp;…</a><div class="gs_gray">STARSurg Collaborative, TM Drake, LK Cheung, F Gaba, J Glasbey, ...</div><div class="gs_gray">Anaesthesia 73 (10), 1214-1222<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15710919331380502864" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Efficacy and safety of radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases who did or did not receive prior docetaxel (D&nbsp;…</a><div class="gs_gray">NJ Vogelzang, SI Helle, DC Johannessen, JM O'Sullivan, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), 5068-5068<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10035514585408984692" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer: recommendations from a European Expert Working Group</a><div class="gs_gray">JM O'Sullivan, J Carles, R Cathomas, A Gomez-Iturriaga, D Heinrich, ...</div><div class="gs_gray">European urology oncology 3 (4), 455-463<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18231911129873369739" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Computed tomography-based radiomics for risk stratification in prostate cancer</a><div class="gs_gray">SOS Osman, RTH Leijenaar, AJ Cole, CA Lyons, AR Hounsell, KM Prise, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 105 (2), 448-456<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4157489492167971230" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Unintended cardiac irradiation during left-sided breast cancer radiotherapy</a><div class="gs_gray">RB Goody, J O’Hare, K McKenna, L Dearey, J Robinson, P Bell, J Clarke, ...</div><div class="gs_gray">The British journal of radiology 86 (1022), 20120434<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=496442520720804576" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Phase I/II trials of <sup>186</sup>Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival</a><div class="gs_gray">AM Denis-Bacelar, SJ Chittenden, DP Dearnaley, A Divoli, JM O’Sullivan, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 44 (4), 620-629<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2152307697008440533" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array</a><div class="gs_gray">EJ Saunders, T Dadaev, DA Leongamornlert, AA Al Olama, S Benlloch, ...</div><div class="gs_gray">British journal of cancer 114 (8), 945-952<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4254410204832646723" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:vDijr-p_gm4C" class="gsc_a_at">Cellular signalling effects in high precision radiotherapy</a><div class="gs_gray">SJ McMahon, CK McGarry, KT Butterworth, S Jain, JM O’Sullivan, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 60 (11), 4551<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8101174164989485200" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself</a><div class="gs_gray">CM McCrudden, MG O’Rourke, KE Cherry, HF Yuen, D O’Rourke, ...</div><div class="gs_gray">PloS one 10 (2), e0118187<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18045295053972045014" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Three cemetery-settlement excavations in County Galway at Carrowkeel, Treanbaun and Owenbristy</a><div class="gs_gray">J Lehane, MM Pérez, J O’Sullivan, B Wilkins</div><div class="gs_gray">Death and Burial in Early Medieval Ireland in the Light of Recent&nbsp;…<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4301910422965501198" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Failure to achieve a PSA level≤ 1 ng/ml after neoadjuvant LHRHa therapy predicts for lower biochemical control rate and overall survival in localized prostate cancer treated&nbsp;…</a><div class="gs_gray">DM Mitchell, J McAleese, RM Park, DP Stewart, S Stranex, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 69 (5), 1467-1471<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2721865841061931576" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Reducing errors in prostate tracking with an improved fiducial implantation protocol for CyberKnife based stereotactic body radiotherapy (SBRT)</a><div class="gs_gray">OE Holmes, J Gratton, J Szanto, E Vandervoort, J Doody, E Henderson, ...</div><div class="gs_gray">Journal of Radiosurgery and SBRT 5 (3), 217<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5195184730357634717" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:foquWX3nUaYC" class="gsc_a_at">Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer&nbsp;…</a><div class="gs_gray">L Andronis, I Goranitis, S Pirrie, A Pope, D Barton, S Collins, A Daunton, ...</div><div class="gs_gray">England<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12943240096106556920" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:4X0JR2_MtJMC" class="gsc_a_at">(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical&nbsp;…</a><div class="gs_gray">KA Lee, M Dunne, C Small, PJ Kelly, O McArdle, J O’Sullivan, D Hacking, ...</div><div class="gs_gray">Acta Oncologica 57 (7), 965-972<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12893557464674298683" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:artPoR2Yc-kC" class="gsc_a_at">Efficacy of a rectal spacer with prostate SABR—first UK experience</a><div class="gs_gray">RB King, SOS Osman, C Fairmichael, DM Irvine, CA Lyons, A Ravi, ...</div><div class="gs_gray">The British journal of radiology 91 (xxxx), 20170672<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2217236492799542600" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:fFSKOagxvKUC" class="gsc_a_at">A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer&nbsp;…</a><div class="gs_gray">JM van Dodewaard-de Jong, JMH de Klerk, HJ Bloemendal, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 44 (8), 1319-1327<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13824207824002699864" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:XvxMoLDsR5gC" class="gsc_a_at">StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial</a><div class="gs_gray">JE Neffendorf, R Desai, Y Wang, J Kelly, C Murphy, BC Reeves, ...</div><div class="gs_gray">Trials 17 (1), 1-12<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3212652619540292625" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers.</a><div class="gs_gray">W Oyen, F Sundram, AR Haug, K Kairemo, V Lewington, H Mäenpää, ...</div><div class="gs_gray">Journal of OncoPathology 3 (1)<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=570124347071827955" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:rbm3iO8VlycC" class="gsc_a_at">Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study</a><div class="gs_gray"></div><div class="gs_gray">Journal of British Surgery 107 (8), 1023-1032<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3024358412598545673" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable‐risk prostate cancer patients: A 9‐month longitudinal study</a><div class="gs_gray">E Ruane‐McAteer, S Porter, J O'Sullivan, M Dempster, G Prue</div><div class="gs_gray">Psycho‐oncology 28 (8), 1743-1752<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5146674791655158446" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:nRpfm8aw39MC" class="gsc_a_at">Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): modelling to estimate long-term survival, quality-adjusted survival, and cost&nbsp;…</a><div class="gs_gray">BS Woods, E Sideris, MR Sydes, MR Gannon, MKB Parmar, M Alzouebi, ...</div><div class="gs_gray">European urology oncology 1 (6), 449-458<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3242259830409658553" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:AHdEip9mkN0C" class="gsc_a_at">High-risk cutaneous malignancies and immunosuppression: challenges for the reconstructive surgeon in the renal transplant population</a><div class="gs_gray">L Kearney, D Hogan, P Conlon, M Roche, JP O'Neill, JB O'Sullivan</div><div class="gs_gray">Journal of Plastic, Reconstructive &amp; Aesthetic Surgery 70 (7), 922-930<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15410543939933186701" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning</a><div class="gs_gray">GG Hanna, JR Van Sörnsen De Koste, KJ Carson, JM O'Sullivan, ...</div><div class="gs_gray">The British journal of radiology 84 (1006), 919-929<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=432915590426013259" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:wMgC3FpKEyYC" class="gsc_a_at">A study on perceived weight, eating habits, and unhealthy weight control behavior in Korean adolescents</a><div class="gs_gray">NS Yu</div><div class="gs_gray">International Journal of Human Ecology 12 (2), 13-24<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=510495527357812010" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma</a><div class="gs_gray">DS Gogarty, P Lennon, S Deady, JB O’Sullivan, O McArdle, M Leader, ...</div><div class="gs_gray">European Archives of Oto-Rhino-Laryngology 274 (2), 953-960<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10944666517567368650" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:XoXfffV-tXoC" class="gsc_a_at">Safety considerations when treating myelofibrosis</a><div class="gs_gray">JM O’Sullivan, DP McLornan, CN Harrison</div><div class="gs_gray">Expert opinion on drug safety 15 (9), 1185-1192<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=176401193464992477" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:FPJr55Dyh1AC" class="gsc_a_at">External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic&nbsp;…</a><div class="gs_gray">SE Finkelstein, JM Michalski, JM O'Sullivan, C Parker, JE Garcia-Vargas, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (7_suppl), 182-182<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14385333192020875807" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer–a feasibility study</a><div class="gs_gray">JM O'Sullivan, DP Hollywood, N Cody, J Dillon, S Buckney, MJ Moriarty, ...</div><div class="gs_gray">Clinical Oncology 14 (3), 236-240<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14123823488386703632" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Myelofibrosis: Clinicopathologic Features</a><div class="gs_gray">JM O’Sullivan, CN Harrison</div><div class="gs_gray">Prognosis and Management<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9527400604460632065" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:uVUOdF_882EC" class="gsc_a_at">The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.</a><div class="gs_gray">CR Cardwell, JM O’Sullivan, S Jain, MT Harbinson, MB Cook, BM Hicks, ...</div><div class="gs_gray">Epidemiology (Cambridge, Mass.) 31 (3), 432<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8902286136120916935" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Mechanistic modeling of radium-223 treatment of bone metastases</a><div class="gs_gray">HMR Moreira, FDCG Liberal, JM O'Sullivan, SJ McMahon, KM Prise</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 103 (5), 1221-1230<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9649017630611335024" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:GnPB-g6toBAC" class="gsc_a_at">Inverse planned constant dose rate volumetric modulated arc therapy (VMAT) as an efficient alternative to five-field intensity modulated radiation therapy (IMRT) for prostate</a><div class="gs_gray">CK McGarry, SJ McMahon, D Craft, JM O'Sullivan, KM Prise, AR Hounsell</div><div class="gs_gray">Journal of Radiotherapy in Practice 13 (1), 68-78<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13178574484326583445" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients&nbsp;…</a><div class="gs_gray">C Parker, D Heinrich, SI Helle, J O'Sullivan, S Fossa, A Chodacki, ...</div><div class="gs_gray">European Urology Supplements 11, E130-U523<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8638011227355614813" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Essential thrombocythaemia treated with recombinant interferon:‘real world'United Kingdom referral centre experience</a><div class="gs_gray">J Desterro, DP McLornan, N Curto Garcia, J O'Sullivan, S Alimam, ...</div><div class="gs_gray">British journal of haematology 186 (4), 561-564<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3629327975170120165" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy</a><div class="gs_gray">AM Denis-Bacelar, SJ Chittenden, VR McCready, A Divoli, DP Dearnaley, ...</div><div class="gs_gray">The British journal of radiology 91 (1084), 20170795<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15698276809196824375" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:bKqednn6t2AC" class="gsc_a_at">A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases</a><div class="gs_gray">AM Denis-Bacelar, SJ Chittenden, I Murray, A Divoli, VR McCready, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 62 (7), 2859<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18111007539880178118" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ILKRHgRFtOwC" class="gsc_a_at">External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone&nbsp;…</a><div class="gs_gray">SE Finkelstein, JM Michalski, J O'Sullivan, C Parker, J Garcia-Vargas, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 93 (3), S201<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17267346822985424595" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Time and cell type dependency of survival responses in co-cultured tumor and fibroblast cells after exposure to modulated radiation fields</a><div class="gs_gray">KT Butterworth, SJ McMahon, JC McKee, G Patel, M Ghita, AJ Cole, ...</div><div class="gs_gray">Radiation research 183 (6), 656-664<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5687845441081121084" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:fbc8zXXH2BUC" class="gsc_a_at">A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy</a><div class="gs_gray">CA Lyons, RB King, SOS Osman, SJ McMahon, JM O’Sullivan, ...</div><div class="gs_gray">Radiation Oncology 12 (1), 1-8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7787457853266568297" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields</a><div class="gs_gray">KT Butterworth, KM Redmond, SJ McMahon, AJ Cole, S Jain, ...</div><div class="gs_gray">International journal of radiation biology 91 (3), 257-261<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18243128760843599403" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:JQOojiI6XY0C" class="gsc_a_at">Radium-223 dichloride for the treatment of metastatic prostate cancer</a><div class="gs_gray">PG Turner, J O’Sullivan</div><div class="gs_gray">Expert opinion on pharmacotherapy 15 (14), 2105-2111<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12305933656902809707" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:VL0QpB8kHFEC" class="gsc_a_at">BINGO: targeted therapy for advanced biliary-tract cancer</a><div class="gs_gray">JW Valle</div><div class="gs_gray">The Lancet Oncology 15 (8), 778-780<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16855877027081885554" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:XiVPGOgt02cC" class="gsc_a_at">Investigating the influence of respiratory motion on the radiation induced bystander effect in modulated radiotherapy</a><div class="gs_gray">AJ Cole, CK McGarry, KT Butterworth, SJ McMahon, AR Hounsell, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 58 (23), 8311<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16786275356459665346" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Complications of treatment with local field external beam radiotherapy for localized prostate cancer</a><div class="gs_gray">JM O'Sullivan, A Gribbin, J Taylor, L O'Neill, S Cosgrove, JG Armstrong</div><div class="gs_gray">Clinical Oncology 12 (4), 217-221<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7610402819792601863" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:jSAVyFp_754C" class="gsc_a_at">611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476)</a><div class="gs_gray">N James, H Rush, N Clarke, G Attard, A Cook, D Dearnaley, S Gillessen, ...</div><div class="gs_gray">Annals of Oncology 31, S509<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17988207384290163362" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Impact of prostate cancer hypofractionation on patient reported outcomes: baseline to 5 years change in the CHHIP trial</a><div class="gs_gray">J Staffurth, J Haviland, A Wilkins, I Syndikus, V Khoo, D Bloomfield, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 102 (3), S1-S2<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9699918864152833976" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:lvd772isFD0C" class="gsc_a_at">Adding abiraterone for patients (pts) with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Outcomes in non-metastatic (M0) patients from&nbsp;…</a><div class="gs_gray">N James, J De Bono, MR Spears, NW Clarke, MD Mason, D Dearnaley, ...</div><div class="gs_gray">Annals of Oncology 28, v620<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13776354829837799329" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:gsN89kCJA0AC" class="gsc_a_at">Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients&nbsp;…</a><div class="gs_gray">JGS O’Sullivan, A Heidenreich, D Heinrich, J Gratt, J Lévy</div><div class="gs_gray">European society for medical oncology, Vienna, Austria, 2015. Abstract 2561<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2457238252775995502" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:N5tVd3kTz84C" class="gsc_a_at">Siltuximab in transplant-ineligible patients with myeloma</a><div class="gs_gray">S Bagcchi</div><div class="gs_gray">The Lancet Oncology 15 (8), e309<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5585884943204039272" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:qUcmZB5y_30C" class="gsc_a_at">Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer.</a><div class="gs_gray">M Ranson, RH Wilson, JM O'Sullivan, M Maruoka, A Yamaguchi, ...</div><div class="gs_gray">International journal of clinical pharmacology and therapeutics 48 (11), 708-717<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5102595379217230177" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Problems in comparing population studies of diabetes</a><div class="gs_gray">JB O'Sullivan</div><div class="gs_gray">Excerpta Medica Foundation, International Congress, Series 172<span class="gs_oph">, 1969</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13147550557944002767" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1969</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression</a><div class="gs_gray">PG Thirion, MT Dunne, PJ Kelly, A Flavin, JM O’Sullivan, D Hacking, ...</div><div class="gs_gray">British journal of cancer 122 (9), 1315-1323<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8833989891718283713" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Ade32sEp0pkC" class="gsc_a_at">Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy</a><div class="gs_gray">AGM O'Neill, SO Osman, S Jain, AR Hounsell, JM O'Sullivan</div><div class="gs_gray">Technical innovations &amp; patient support in radiation oncology 9, 35-40<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9628815664891742294" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:SpbeaW3--B0C" class="gsc_a_at">An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol</a><div class="gs_gray">E Ruane-McAteer, J O’Sullivan, S Porter, L Venderbos, G Prue</div><div class="gs_gray">BMC cancer 16 (1), 1-8<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13291481761386884562" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_5tno0g5mFcC" class="gsc_a_at">Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an&nbsp;…</a><div class="gs_gray">D Heinrich, S Gillessen, A Heidenreich, D Keizman, JM O'Sullivan, ...</div><div class="gs_gray">Annals of Oncology 27, vi255<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12136248199276508795" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Development of a novel experimental model to investigate radiobiological implications of respiratory motion in advanced radiotherapy</a><div class="gs_gray">AJ Cole, CK McGarry, KT Butterworth, KM Prise, JM O'Sullivan, ...</div><div class="gs_gray">Physics in Medicine &amp; Biology 57 (22), N411<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17973265290386419817" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:r0BpntZqJG4C" class="gsc_a_at">Tumor Dosimetry on SPECT <sup>186</sup>Re-HEDP Scans: Variations in the Results from the Reconstruction Methods Used</a><div class="gs_gray">A Divoli, G Bloch, S Chittenden, A Malaroda, JM O'Sullivan, DP Dearnaley, ...</div><div class="gs_gray">Cancer biotherapy &amp; radiopharmaceuticals 22 (1), 121-124<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9069906883910872285" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)</a><div class="gs_gray">M Brown, M Murphy, L McDermott, H McAneney, JM O’Sullivan, S Jain, ...</div><div class="gs_gray">Pilot and feasibility studies 5 (1), 1-11<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17847951049056239633" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Radium-223 (Ra-223) therapy after abiraterone (Abi): analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with&nbsp;…</a><div class="gs_gray">K Miller, D Heinrich, JM O’Sullivan, J Carles, M Wirth, S Nilsson, L Huang, ...</div><div class="gs_gray">Annals of Oncology 29, viii287<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11623978279679598736" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:owLR8QvbtFgC" class="gsc_a_at">Radium-223 from bench to bedside–future directions for targeted alpha therapy</a><div class="gs_gray">JM O’Sullivan</div><div class="gs_gray">Journal-Radium-223 from Bench to Bedside–Future Directions for Targeted&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12591973651567183856" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:OTTXONDVkokC" class="gsc_a_at">Opportunities for research in molecular radiotherapy</a><div class="gs_gray">GD Flux, J O'Sullivan, MN Gaze, KM Prise</div><div class="gs_gray">The British journal of radiology 90 (1071), 20160921<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1039667829853784169" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Radium-223 (Ra-223) in asymptomatic metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP).</a><div class="gs_gray">A Heidenreich, S Gillessen, D Heinrich, D Keizman, JM O'Sullivan, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (6_suppl), 158-158<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10201693984207667395" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:uLbwQdceFCQC" class="gsc_a_at">External-beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone&nbsp;…</a><div class="gs_gray">JM O'Sullivan, O Sartor, C Parker, P Hoskin, A Widmark, B Mellado, ...</div><div class="gs_gray">Annals of Oncology 25, iv263<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14023966327223513737" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases: baseline&nbsp;…</a><div class="gs_gray">J O'Sullivan, DC Johannessen, A Widmark, I Syndikus, N James, ...</div><div class="gs_gray">European Journal of Cancer 49 (Supplement 2), S688-S688, Meeting Abstract: 2877<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6601864711508736226" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from STAMPEDE (MRC PR08, CRUK/06/019), a randomized controlled&nbsp;…</a><div class="gs_gray">ND James, MR Sydes, MD Mason, NW Clarke, J Anderson, DP Dearnaley, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (5_suppl), 26-26<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2824742308915899980" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:4JMBOYKVnBMC" class="gsc_a_at">A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC&nbsp;…</a><div class="gs_gray">C Parker, R Hoskin, S Pascoe, A Chodack, J O'Sullivan, JR Germa, ...</div><div class="gs_gray">Ejc Supplements 7, 406-406<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=870282802368250459" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Prediction of response of skeletal metastases from cancer of the prostate to high activity Re-186 HEDP therapy.</a><div class="gs_gray">VR McCready, J O'Sullivan, D Dearnaley, G Cook</div><div class="gs_gray">The Journal of Nuclear Medicine 43, 316P-316P<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6071907119014612746" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Quantitative analysis of bone scans to determine if the dose to individual metastases from high activity Re186HEDP therapy depends upon the number of metastases</a><div class="gs_gray">VR McCready, J O'Sullivan, D Dearnaley, J Treleaven</div><div class="gs_gray">Radiology 221, 344-344<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16941119183496729032" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:DrR-2ekChdkC" class="gsc_a_at">Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma</a><div class="gs_gray">CWD Armstrong, JA Coulter, CW Ong, PJ Maxwell, S Walker, ...</div><div class="gs_gray">NAR cancer 2 (3), zcaa012<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2220728956476029975" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kF1pexMAQbMC" class="gsc_a_at">Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update&nbsp;…</a><div class="gs_gray">DP Dearnaley, C Griffin, I Syndikus, V Khoo, AJ Birtle, A Choudhury, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (6_suppl), 325-325<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14018377374172606373" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PyEswDtIyv0C" class="gsc_a_at">Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease</a><div class="gs_gray">J Nikles, JD O'Sullivan, GK Mitchell, SS Smith, JM McGree, H Senior, ...</div><div class="gs_gray">Contemporary clinical trials communications 15, 100397<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13889179191652883072" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Individual patient data meta-analysis of evar trial 1, the dutch randomised endovascular aneurysm management trial, the open versus endovascular repair trial and anévrysme de l&nbsp;…</a><div class="gs_gray">R Patel, JT Powell, MJ Sweeting, DM Epstein, JK Barrett, RM Greenhalgh</div><div class="gs_gray">The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14873572525399257763" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life</a><div class="gs_gray">SOS Osman, S Horn, D Brady, SJ McMahon, ABM Yoosuf, D Mitchell, ...</div><div class="gs_gray">Radiation Oncology 12 (1), 1-12<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11225294549382887475" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:yFnVuubrUp4C" class="gsc_a_at">Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients&nbsp;…</a><div class="gs_gray">F Saad, D Heinrich, S Gillessen, J O’Sullivan, J Carles, M Wirth, K Miller, ...</div><div class="gs_gray">European Urology Supplements 3 (16), e93-e94<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1985197073144814173" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program</a><div class="gs_gray">M Lawler, A Gavin, M Salto‐Tellez, RD Kennedy, S Van Schaeybroeck, ...</div><div class="gs_gray">Cancer 122 (5), 664-673<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10278081583441789031" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:dBIO0h50nwkC" class="gsc_a_at">Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer&nbsp;…</a><div class="gs_gray">ND James, L Andronis, I Goranitis, S Pirrie, A Pope, D Barton, A Daunton, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), e16108-e16108<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5592024859672635203" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:27LrP4qxOz0C" class="gsc_a_at">Developing and evaluating a psychosocial intervention for men with prostate cancer and their partners</a><div class="gs_gray">E McCaughan, K Parahoo, S McKenna, O McSorley, G Prue, J O'Sullivan, ...</div><div class="gs_gray">University of Ulster<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13155147619321096500" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:abG-DnoFyZgC" class="gsc_a_at">Neoadjuvant Hormone Therapy for Radical Prostate Radiotherapy: Bicalutamide Monotherapy vs. Luteinizing Hormone–Releasing Hormone Agonist Monotherapy: A Single-Institution&nbsp;…</a><div class="gs_gray">U McGivern, DM Mitchell, C McDowell, J O'Hare, G Corey, JM O'Sullivan</div><div class="gs_gray">Clinical genitourinary cancer 10 (3), 190-195<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7795060347866813930" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:uWQEDVKXjbEC" class="gsc_a_at">A randomised controlled trial to evaluate the efficacy of a dietary and physical activity intervention on prostate cancer patients receiving androgen deprivation therapy</a><div class="gs_gray">R Oneill, L Murray, J O'Sullivan, F Haseen, MM Cantwell</div><div class="gs_gray">Proceedings of the Nutrition Society 71 (OCE2)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9028112257818541745" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:TFP_iSt0sucC" class="gsc_a_at">Gold nanoparticles cause radiosensitization in prostate cancer cell lines in hypoxic conditions</a><div class="gs_gray">S Jain, K Butterworth, KM Prise, JM O'Sullivan, DG Hirst</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 72 (1), S715-S716<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2655275496261782573" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells</a><div class="gs_gray">F Amoroso, K Glass, R Singh, F Liberal, RE Steele, S Maguire, ...</div><div class="gs_gray">Scientific reports 11 (1), 1-16<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3953857715663922131" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:raTqNPD5sRQC" class="gsc_a_at">Corrigendum to Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial&nbsp;…</a><div class="gs_gray">NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...</div><div class="gs_gray">Ann Oncol, 442-442<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15899593044815457725" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:1lhNe0rCu4AC" class="gsc_a_at">TRUFU: Therapeutic radiographer undertaking follow up for prostate cancer patients</a><div class="gs_gray">SM Hetherington, T Gilleece, P Shepherd, K Crowther, J O'Sullivan, ...</div><div class="gs_gray">Radiography 24 (4), 298-303<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18179479216647016165" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">First Results from the ADRRAD Trial–Combination Androgen Deprivation Therapy (ADT), Whole Pelvis Radiotherapy (WPRT) and Radium 223 in Recently Diagnosed Metastatic Hormone&nbsp;…</a><div class="gs_gray">PG Turner, S Jain, DM Mitchell, A Hounsell, S Biggart, JM O'Sullivan</div><div class="gs_gray">Clinical Oncology 30 (3), 196<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=867416043151930834" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:wKETBy42zhYC" class="gsc_a_at">A cognitive-emotional see-saw: Men’s experiences of undergoing active surveillance for prostate cancer</a><div class="gs_gray">E Ruane-McAteer, S Porter, J O'Sullivan, G Prue</div><div class="gs_gray">British Psychological Society-Male Psychology Conference<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2420725747418697729" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:OR75R8vi5nAC" class="gsc_a_at">A metastatic biology gene expression assay to predict the risk of distant metastases in patients with localized prostate cancer treated with primary radical treatment</a><div class="gs_gray">S Jain, C Lyons, S Walker, S McQuaid, S Hynes, D Mitchell, B Pang, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 99 (2), S97-S98<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14614303999184536079" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ODE9OILHJdcC" class="gsc_a_at">Relationship between quality of life and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients in ALSYMPCA.</a><div class="gs_gray">S Nilsson, AO Sartor, NJ Vogelzang, RE Coleman, JM O'Sullivan, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (6_suppl), 177-177<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1401013974281401264" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Recognizing symptom burden in advanced prostate cancer: A global patient and caregiver survey.</a><div class="gs_gray">WK Oh, BF Tombal, A Delacruz, B Tomlinson, A Vella Ripley, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 10124-10124<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15440977985778186222" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:a3BOlSfXSfwC" class="gsc_a_at">PO-0739: Plasma citrulline is a potential biomarker for small bowel toxicity following radiotherapy for prostate cancer</a><div class="gs_gray">D Brady, S Horn, S Yakkundi, CK McGarry, AR Hounsell, KM Prise, ...</div><div class="gs_gray">Radiotherapy and Oncology 115, S366<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4508978245339926933" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:W5xh706n7nkC" class="gsc_a_at">NICE guidance on dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma</a><div class="gs_gray">H Tucker, N Umeweni, J Robertson, J Adam</div><div class="gs_gray">The Lancet Oncology 13 (15), 1425-1426<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14673855653931072225" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ns9cj8rnVeAC" class="gsc_a_at">684 RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES A PHASE&nbsp;…</a><div class="gs_gray">O Sartor, D Heinrich, SI Helle, JM O'Sullivan, A Chodacki, T Demkow, ...</div><div class="gs_gray">The Journal of Urology 187 (4S), e279-e279<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15771350753154602741" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NMxIlDl6LWMC" class="gsc_a_at">The experience and coping behaviours of men with prostate cancer receiving combined radiotherapy and hormone treatment: Abstract ID:# 0119</a><div class="gs_gray">E McCaughan, O McSorley, K Parahoo, G Prue, J O'Sullivan, B Bunting, ...</div><div class="gs_gray">Journal of Men's Health 8 (3), 235-235<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9133155692193920060" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy (a Cochrane systematic review)</a><div class="gs_gray">B Nugent, S Lewis, JM O’Sullivan</div><div class="gs_gray">Journal of Human Nutrition and Dietetics 24 (3), 298-299<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2978921485340143420" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Does PET-CT in the radiotherapy treatment planning process for non-small cell lung cancer alter treatment volumes in already PET-CT staged patients?</a><div class="gs_gray">GG Hanna, KJ Carson, J McAleese, DP Stewart, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 72 (1), S443<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13785645026024561256" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:isC4tDSrTZIC" class="gsc_a_at">The relationship between skeletal metastatic load and therapeutic activity requirement in prostate cancer</a><div class="gs_gray">V McCready, J O'Sullivan, F Buffa, G Cook, G Flux, D Dearnaley, R Grant</div><div class="gs_gray">European Journal of Nuclear Medicine 28, 1054<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4190682349990603991" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort study</a><div class="gs_gray">CR Cardwell, JM O’Sullivan, S Jain, BM Hicks, PA Devine, ...</div><div class="gs_gray">Prostate cancer and prostatic diseases, 1-8<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14754303116302449541" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Xl6nMSl579sC" class="gsc_a_at">Performance of soluble fms-like tyrosine kinase-1–to–placental growth factor ratio of≥ 85 for ruling in preeclampsia within 4 weeks</a><div class="gs_gray">AS Cerdeira, J O’Sullivan, EO Ohuma, T James, AT Papageorghiou, ...</div><div class="gs_gray">American Journal of Obstetrics &amp; Gynecology 224 (3), 322-323<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10826691490262992534" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:IsPWOBWtZBwC" class="gsc_a_at">A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer</a><div class="gs_gray">AHD Alshehri, SOS Osman, KM Prise, C Campfield, PG Turner, ...</div><div class="gs_gray">The British Journal of Radiology 93 (1115), 20200775<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15909071143664056584" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Results of the ADRRAD Trial of pelvic IMRT plus radium-223 in men with mHSPC metastatic to bone.</a><div class="gs_gray">J O'Sullivan, PG Turner, S Jain, A Grey, S Biggart, AR Hounsell, A Cole</div><div class="gs_gray">Journal of Clinical Oncology 38 (6_suppl), 136-136<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5620391224447167258" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:mUJArPsKIAAC" class="gsc_a_at">Pacritinib demonstrates efficacy versus best available therapy in myelofibrosis patients with severe thrombocytopenia in two phase 3 studies</a><div class="gs_gray">RA Mesa, M Talpaz, JJ Kiladjian, CN Harrison, S Verstovsek, SA Buckley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15569448682961325133" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:CYCckWUYoCcC" class="gsc_a_at">CT-based radiomics for risk stratification in prostate cancer</a><div class="gs_gray">S Osman, RTH Leijenaar, AJ Cole, AR Hounsell, KM Prise, JM O'Sullivan, ...</div><div class="gs_gray">RADIOTHERAPY AND ONCOLOGY 133, S209-S209<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17688039400286620726" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NDuN12AVoxsC" class="gsc_a_at">Modulating the unfolded protein response: Impacts of radiation on the response of prostate cancer cells to ONC201</a><div class="gs_gray">F Amoroso, K Glass, F Liberal, RE Steele, S Maguire, R Tarapore, ...</div><div class="gs_gray">bioRxiv, 710400<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15173498655086485445" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) vs. EZ alone in metastatic castration refractory prostate cancer (mCRPC)</a><div class="gs_gray">BL Maughan, A Hahn, J Hoffman, K Morton, S Gupta, J Batten, J Thorley, ...</div><div class="gs_gray">Annals of Oncology 29, viii287-viii288<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9294537420299782262" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Semi-permanent tattoos in breast radiotherapy (STaBRad) study: a randomised-controlled clinical trial comparing the ‘Precision Plus Micropigmentation System’to permanent skin&nbsp;…</a><div class="gs_gray">A O’Neill, S McAleer, H McCarty, J Clarke, A Drake, J Hurwitz, A Clayton, ...</div><div class="gs_gray">Journal of Radiotherapy in Practice 17 (1), 12-19<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4620696865402956802" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:0CzhzZyukY4C" class="gsc_a_at">CASPIR trial: Using prostatic calculi as an alternative to fiducial markers for IGRT in for localized prostate cancer.</a><div class="gs_gray">AGM O'Neill, R King, S Osman, S Jain, AR Hounsell, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 36 (6_suppl), 60-60<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11555662056610138992" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:gVv57TyPmFsC" class="gsc_a_at">Reducing errors in prostate tracking with an improved fiducial implantation protocol for stereotactic body radiotherapy (SBRT)</a><div class="gs_gray">OE Holmes, J Gratton, J Szanto, E Vandervoort, J Doody, E Henderson, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 99 (2), E239<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17181326176237765313" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:8d8msizDQcsC" class="gsc_a_at">SPORT high-risk trial: A randomised feasibility study evaluating stereotactic prostate radiotherapy in high-risk localised prostate cancer with or without elective nodal&nbsp;…</a><div class="gs_gray">C Lyons, C McGarry, A Hounsell, S Hynds, K Prise, J O'Sullivan, S Jain</div><div class="gs_gray">European Journal of Surgical Oncology 42 (11), S235<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12636874718291472139" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:4hFrxpcac9AC" class="gsc_a_at">We can cure, but can we care? Favourable-risk disease≠ favourable psychological wellbeing in men recently diagnosed with PCa: baseline findings from a prospective&nbsp;…</a><div class="gs_gray">E Ruane-McAteer, JM O'Sullivan, S Porter, G Prue</div><div class="gs_gray">Psycho-oncology, 190<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16833269770756014216,10538058504377250597" class="gsc_a_ac gs_ibl">1</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="ojU5mu4AAAAJ:4hFrxpcac9AC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HeT0ZceujKMC" class="gsc_a_at">A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to&nbsp;…</a><div class="gs_gray">JM van Dodewaard-de Jong, H Bloemendal, JMH de Klerk, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 5081-5081<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2563242218235662294" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:rmuvC79q63oC" class="gsc_a_at">EP-1377: Consistency of cone beam CT-derived bladder volume and inflow during localized prostate cancer IMRT</a><div class="gs_gray">CJ Ho, CK McGarry, JY Sun, CA Lyons, RB King, S Jain, AR Hounsell, ...</div><div class="gs_gray">Radiotherapy and Oncology 119, S643<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2266336354128773511" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial (vol 2, pg&nbsp;…</a><div class="gs_gray">ND James, MR Spears, NW Clarke</div><div class="gs_gray">Jama Oncology 2 (2), 279-279<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=378692899556998640" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_axFR9aDTf0C" class="gsc_a_at">EP-2110: A study of prostatic calculi: in patients receiving radical radiotherapy for prostate cancer</a><div class="gs_gray">A O'Neill, CA Lyons, S Jain, AR Hounsell, JM O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology 1 (119), S992<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16411878838387446991" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:F1b5ZUV5XREC" class="gsc_a_at">“More than skin deep”: Recurrent primary hand abscesses in a warehouse operative</a><div class="gs_gray">L Kearney, C O’Connor, F Fitzpatrick, JB O’Sullivan</div><div class="gs_gray">Case Reports in Plastic Surgery and Hand Surgery 2 (3-4), 84-87<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10237534770516786975" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic&nbsp;…</a><div class="gs_gray">G Paganelli, C Rossetti, M Aglietta, C Messina, A Versari, JM Michalski, ...</div><div class="gs_gray">Annals of Oncology 26, vi61<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14302398201779410322" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ZuybSZzF8UAC" class="gsc_a_at">VMP using weekly and subcutaneous bortezomib is well tolerated and efficacious for newly diagnosed and relapsed myeloma patients: 154</a><div class="gs_gray">J O'Sullivan, S Kumar, C Yeomans, G Milner, S Schey, M Kazmi, ...</div><div class="gs_gray">British Journal of Haematology 165, 64-65<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14205970973057912326" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">How Do You Know If It Is Any Good?: The Development and Application of an Evaluative Framework to Assess Contemporary Children's Books</a><div class="gs_gray">K Lee, P Perger, M Dunn, J O'Sullivan</div><div class="gs_gray">Handbook of research on education and technology in a changing society, 1-15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3383872870884375822" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:j8SEvjWlNXcC" class="gsc_a_at">310: The novel use of BAMLET in the treatment of oral squamous cell carcinoma</a><div class="gs_gray">N Sinevici, N Harte, KH Mok, Y Xie, J O’Sullivan</div><div class="gs_gray">European Journal of Cancer, S74<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12770844459137237435" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:738O_yMBCRsC" class="gsc_a_at">Impact of 4-Dimensional CT (4D-CT) on Toxicity, Outcomes, and Dose Escalation for Radical Lung Cancer Radiation Therapy</a><div class="gs_gray">A Cole, JM O'Hare, SJ McMahon, CK McGarry, J McAleese, ...</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 87 (2), S517<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6112548073060771527" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HE397vMXCloC" class="gsc_a_at">Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha-pharmaceutical: Results from a phase III randomized trial (ALSYMPCA) in patients with&nbsp;…</a><div class="gs_gray">MA Kuczyk, C Parker, D Heinrich, JM O'Sullivan, SD Fossa, A Chodacki, ...</div><div class="gs_gray">Onkologie 35, 182-182<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17556699614537024719" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WA5NYHcadZ8C" class="gsc_a_at">EP-1587 cell survival responses to modulated proton beams delivered by passive scattering and pencil beam scanning</a><div class="gs_gray">CK McGarry, KT Butterworth, B Clasie, JSA Carabe-Fernandez, ...</div><div class="gs_gray">Radiotherapy and Oncology, S608-S609<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17867711117601373082" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:bnK-pcrLprsC" class="gsc_a_at">Debating controversies in the management of locally advanced prostate cancer</a><div class="gs_gray">HA Payne, JM O'Sullivan, J Troup</div><div class="gs_gray">Trends in Urology &amp; Men's Health 2 (3), 38-41<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16588307962071701698" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:9vf0nzSNQJEC" class="gsc_a_at">How does neoadjuvant bicalutamide 150 mg monotherapy compare to lutenising hormone-releasing hormone agonist (LHRHa) therapy in localized prostate cancer treated with radical&nbsp;…</a><div class="gs_gray">U McGivern, DM Mitchell, J O'Hare, G Corey, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 29 (7_suppl), 146-146<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13793787127719380118" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:UmS_249rOGwC" class="gsc_a_at">18F-FDG PET-CT based target volume definition in non-small cell lung cancer reduces inter-observer variation in already PET-CT staged patients</a><div class="gs_gray">GG Hanna, J McAleese, KJ Carson, DP Stewart, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">Lung Cancer, S34-S35<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13041361497307695395" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">48LBA Algorithmic classifiers to diagnose bladder cancer</a><div class="gs_gray">K Williamson, F Abogunrin, M Stevenson, J O'Sullivan, B Duggan, ...</div><div class="gs_gray">EJC Supplements 3 (7), 21<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15814612776247427853" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:u_35RYKgDlwC" class="gsc_a_at">Assessing the daily consistency of bladder filling prior to conformal prostate radiotherapy using an ultrasonic Bladderscan device</a><div class="gs_gray">S Hynds, C McGarry, D Mitchell, S Early, L Shum, D Stewart, J Harney, ...</div><div class="gs_gray">Radiotherapy and Oncology, S130<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3666768131667128699" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:hMod-77fHWUC" class="gsc_a_at">What is the shelf life of PET-CT staging of the mediastinum in non-small cell lung cancer?</a><div class="gs_gray">G Hanna, KG McManus, T Lynch, G Gracey, J O'Sullivan, J McAleese</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8017602060026493374" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Does PET-CT in the radiotherapy treatment planning process for Non-Small Cell Lung Cancer reduce inter-observer variability?</a><div class="gs_gray">G Hanna, K Carson, J McAleese, V Cosgrove, D Stewart, R Eakin, ...</div><div class="gs_gray">Radiotherapy and Oncology 88, S280-S280<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4777408340259784872" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:BqipwSGYUEgC" class="gsc_a_at">Strategies for the implementation of chemotherapy and radiotherapy</a><div class="gs_gray">P Scullin, JM O’Sullivan, CC Parker</div><div class="gs_gray">Metastasis of Prostate Cancer, 309-335<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11287628656889525210" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:35r97b3x0nAC" class="gsc_a_at">Genitourinary tract infections in cancer patients</a><div class="gs_gray">T Nambirajan, JM O’Sullivan</div><div class="gs_gray">Infection in the cancer patient: a practical guide, 101-112<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4039443005902127865" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.</a><div class="gs_gray">J McAleese, J O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology 75 (1), 121<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16476775740345701336" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NhqRSupF_l8C" class="gsc_a_at">Symptom control in urological malignancy</a><div class="gs_gray">AP Doherty, JM O’Sullivan</div><div class="gs_gray">Surgical Palliative Care 1, 173<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7860176458378748131" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:blknAaTinKkC" class="gsc_a_at">New approaches to the use of unsealed source radionuclide therapy for skeletal metastases.</a><div class="gs_gray">J O'Sullivan</div><div class="gs_gray">Kaku igaku. The Japanese journal of nuclear medicine 39 (3), 249-250<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4919510448902457333" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)</a><div class="gs_gray">JN Staffurth, JS Haviland, A Wilkins, I Syndikus, V Khoo, D Bloomfield, ...</div><div class="gs_gray">European Urology Oncology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Wq2b2clWBLsC" class="gsc_a_at">Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer</a><div class="gs_gray">PG Turner, S Jain, A Cole, A Grey, D Mitchell, KM Prise, AR Hounsell, ...</div><div class="gs_gray">Clinical Cancer Research 27 (16), 4549-4556<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease</a><div class="gs_gray">M Bolla, A Neven, P Maingon, C Carrie, A Boladeras, D Andreopoulos, ...</div><div class="gs_gray">Journal of Clinical Oncology, JCO. 21.00855<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Synergistic activity of DNA damage response kinase inhibitors in combination with the targeted alpha therapy radium-223 dichloride for metastatic castration-resistant prostate&nbsp;…</a><div class="gs_gray">VL Dunne, T Wright, F Liberal, JM O'Sullivan, KM Prise</div><div class="gs_gray">Cancer Research 81 (13 Supplement), 3054-3054<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Management of newly diagnosed metastatic hormone‐sensitive prostate cancer: A survey of UK Uro‐oncologists</a><div class="gs_gray">A Bahl, S Crabb, D Ford, R Jones, Z Malik, D Mazhar, J O’Sullivan, ...</div><div class="gs_gray">International journal of clinical practice 75 (4), e13874<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">The stereotactic prostate radiotherapy (SPORT) trial: A randomized feasibility study comparing prostate SABR to prostate and pelvic nodal SABR.</a><div class="gs_gray">C Fairmichael, KM Redmond, SO Osman, CA Lyons, DM Mitchell, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (6_suppl), 248-248<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:L_l9e5I586QC" class="gsc_a_at">Aerobic exercise as an adjuvant therapy in the management of metastatic castrate-resistant prostate cancer: A case study</a><div class="gs_gray">M Brown, D O'Connor, J O'Sullivan, S Jain, G Prue</div><div class="gs_gray">Supportive Care in Cancer, S226-S226<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:UuEBAcK4md4C" class="gsc_a_at">Performance of sFlt-1/PlGF ratio≥ 85 for ruling in preeclampsia within 4 weeks</a><div class="gs_gray">AS Cerdeira, J O’Sullivan, EO Ohuma, T James, AT Papageorghiou, ...</div><div class="gs_gray">American Journal of Obstetrics and Gynecology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Use of bisphosphonates and other bone supportive agents in the management of prostate cancer—A UK perspective</a><div class="gs_gray">H Payne, A Bahl, JM O’Sullivan</div><div class="gs_gray">International Journal of Clinical Practice 74 (11), e13611<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:An6A6Jpfc1oC" class="gsc_a_at">The Impact of PSMA PET-CT on Treatment Decisions in Prostate Cancer–Early Experience in a Single Centre</a><div class="gs_gray">C Rooney, A Henry, A Cole, J O’Sullivan, D Mitchell, S Jain</div><div class="gs_gray">Clinical Oncology 32 (5), e133-e134<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:EPG8bYD4jVwC" class="gsc_a_at">First Survival Data from the ADRRAD Clinical Trial; Pelvic Radiotherapy and Concurrent Radium-223 in Metastatic Hormone Sensitive Prostate Cancer (mHSPC)</a><div class="gs_gray">P Turner, S Jain, A Cole, S Biggart, A Hounsell, J O’Sullivan</div><div class="gs_gray">Clinical Oncology 32 (5), e130-e131<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:rTD5ala9j4wC" class="gsc_a_at">Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution</a><div class="gs_gray">N Gray, CKJ Cheung, A Khalil, J O'Sullivan, B Psaila</div><div class="gs_gray">British Journal of Haematology 189, 76-77<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:pS0ncopqnHgC" class="gsc_a_at">Refining the erythrocytosis diagnostic pathway: an audit of current practice compared to British Society for Haematology guidelines</a><div class="gs_gray">R Williams, N Curto-Garcia, J O'Sullivan, D Radia, D McLornan, ...</div><div class="gs_gray">British Journal of Haematology 189, 74-75<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:qwy9JoKyICEC" class="gsc_a_at">Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells</a><div class="gs_gray">RE Steele, S Maguire, R Tarapore, JE Allen, S Van Schaeybroeck, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma</a><div class="gs_gray">CWD Armstrong, JA Coulter, CW Ong, PJ Maxwell, S Walker, ...</div><div class="gs_gray">bioRxiv<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Erratum to “Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy”[Tech. Innov. Patient Support&nbsp;…</a><div class="gs_gray">AGM O'Neill, SO Osman, S Jain, AR Hounsell, JM O'Sullivan</div><div class="gs_gray">Technical Innovations and Patient Support in Radiation Oncology 12, 65<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:mKu_rENv82IC" class="gsc_a_at">Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective</a><div class="gs_gray">JM O'Sullivan</div><div class="gs_gray">Journal of medical imaging and radiation sciences 50 (4), S31-S33<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Mechanistic Modelling of Radium-223 Treatment of Bone Metastases☆☆☆</a><div class="gs_gray">K Prise, H Moriera, F Liberal, J O’sullivan, S Mcmahon</div><div class="gs_gray">Journal of Medical Imaging and Radiation Sciences 50 (4), S80-S81<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:jFemdcug13IC" class="gsc_a_at">Use of Bone Health Agents (BHAs) in Patients with Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated with Radium-223 after Abiraterone: An Interim Review of&nbsp;…</a><div class="gs_gray">JM O’sullivan, CN Sternberg, L Harshman, J Logue, S Baldari, ...</div><div class="gs_gray">Journal of Medical Imaging and Radiation Sciences 50 (4), S111-S112<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:w0F2JDEymm0C" class="gsc_a_at">UK Single Institution Experience of Mastocytosis: Guy's and St Thomas' NHS Foundation Trust</a><div class="gs_gray">C Oni, M Moonim, J Desterro, C Grattan, N Curto-Garcia, C Woodley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Molecular Analysis in the Pacritinib Dose-Finding PAC203 Study in Patients with Myelofibrosis Refractory or Intolerant to Ruxolitinib</a><div class="gs_gray">J O'Sullivan, JA Taylor, AT Gerds, SA Buckley, CN Harrison, ST Oh, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ziOE8S1-AIUC" class="gsc_a_at">OC-0407 CT-based Radiomics for Risk Stratification in Prostate Cancer</a><div class="gs_gray">S Osman, RTH Leijenaar, AJ Cole, AR Hounsell, KM Prise, JM O'Sullivan, ...</div><div class="gs_gray">Radiotherapy and Oncology 133, S209<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:OBSaB-F7qqsC" class="gsc_a_at">EP-2207 PROMs: Transperineal insertion of prostate markers–results from a prospective clinical trial</a><div class="gs_gray">A O'Neill, K Crowther, D Mitchell, S Jain, A Hounsell, J O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology 133, S1216-S1217<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HGTzPopzzJcC" class="gsc_a_at">EP-2032 Automated Bone Scan Index (aBSI) as an Imaging Biomarker in Castration Sensitive Prostate Cancer</a><div class="gs_gray">A Alshehri, J O'Sullivan, K Prise, S Jain, P Turner, C Campfield, S Biggart, ...</div><div class="gs_gray">Radiotherapy and Oncology 133, S1115-S1116<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Whole genome sequencing for the investigation of rare anaemias: challenges and real-world outcomes</a><div class="gs_gray">A Sanchis-Juan, S McGowan, D Downes, C Babbs, A Bechensteen, ...</div><div class="gs_gray">British Journal of Haematology 185 (S1)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Whole genome sequencing for the investigation of rare anaemias: Challenges and real-world outcomes</a><div class="gs_gray">C Brierley, C Babbs, S McGowan, D Downes, A Sanchis-Juan, Y Aydinok, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185, 115-116<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Successful treatment of chronic neutrophilic leukaemia and associated giant cell arteritis with the combination of ruxolitinib and azacytidine</a><div class="gs_gray">N Herlihy, N Curto-Garcia, J O'Sullivan, D Radia, D McLornan, S Pye, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185, 71-72<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Automated Bone Scan Index (aBSI) as an Imaging Biomarker in Castration Sensitive Metastatic Prostate Cancer in a novel clinical trial with Radium-223 and External Beam Radiotherapy</a><div class="gs_gray">A Alshehri, J O’sullivan, K Prise, S Jain, P Turner, C Campfield, S Biggart, ...</div><div class="gs_gray">Journal of Medical Imaging and Radiation Sciences 50 (1), S26<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Radium-223 (Ra-223) Therapy after Abiraterone: Analysis of Symptomatic Skeletal Events (SSEs) in an International Early Access Program (iEAP) in Patients with Metastatic&nbsp;…</a><div class="gs_gray">JM O’sullivan, K Miller, D Heinrich, J Carles, M Wirth, S Nilsson, ...</div><div class="gs_gray">Journal of Medical Imaging and Radiation Sciences 50 (1), S40<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:q-HalDI95KYC" class="gsc_a_at">In Vitro Radiobiological Effects of Radium-223</a><div class="gs_gray">F Liberal, H Moreira, K Redmond, J O’sullivan, S Mcmahon, K Prise</div><div class="gs_gray">Journal of Medical Imaging and Radiation Sciences 50 (1), S21-S22<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Toxicity results from a novel phase I/II trial of VMAT radiotherapy to prostate and pelvic nodes plus six cycles of radium-223 in mCSPC metastatic to bone post ADT and docetaxel.</a><div class="gs_gray">J O'Sullivan, PG Turner, S Jain, AR Hounsell, DM Mitchell, S Biggart, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (7_suppl), 196-196<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:CdxZDUztZiMC" class="gsc_a_at">Plasma citrulline levels as a biomarker for bowel toxicity in prostate stereotactic radiotherapy with or without pelvic nodal radiation.</a><div class="gs_gray">C Fairmichael, KM Redmond, C Lyons, SR Stevenson, SO Osman, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (7_suppl), 73-73<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:D_tqNUsBuKoC" class="gsc_a_at">EXACT: a multicomponent, feasibility, exercise trial for men with metastatic castrate resistant prostate cancer (a trial in progress)</a><div class="gs_gray">M Brown, MH Murphy, H McAneney, J O'Sullivan, S Jain, G Prue</div><div class="gs_gray">NCRI Cancer Conference 2019<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:prdVHNxh-e8C" class="gsc_a_at">Single Center Retrospective Study of Essential Thrombocythaemia Diagnosed Patients Treated with Interferon-Benefit and Tolerability</a><div class="gs_gray">J Desterro, DP McLornan, N Curto-Garcia, J O'Sullivan, K Shahram, ...</div><div class="gs_gray">Blood 132, 5458<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:XUvXOeBm_78C" class="gsc_a_at">Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide</a><div class="gs_gray">O Chowdhury, J O'Sullivan, N Barkas, G Buck, A Hamblin, A Tefferi, ...</div><div class="gs_gray">Blood 132, 3037<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:L1USKYWJimsC" class="gsc_a_at">Longitudinal Mutational Analysis in Hydroxycarbamide-Resistant/Intolerant Essential Thrombocythemia Treated on the Majic-ET Study</a><div class="gs_gray">J O'Sullivan, A Hamblin, A Panchal, C Yap, S Fox, S Alimam, HMP Dreau, ...</div><div class="gs_gray">Blood 132, 1784<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favourable-risk prostate cancer patients: A 12-month longitudinal study</a><div class="gs_gray">E Ruane-McAteer, S Porter, JM O'Sullivan, M Dempster, GE Prue</div><div class="gs_gray">PSYCHO-ONCOLOGY 27, 170-170<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:7H_MAutzIkAC" class="gsc_a_at">A multicomponent exercise trial for advanced prostate cancer: A study protocol</a><div class="gs_gray">M Brown, G Prue, MH Murphy, H McAneney, J O'Sullivan, S Jain</div><div class="gs_gray">7th Biennial Congress for the International Society for Physical Activity&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kVjdVfd2voEC" class="gsc_a_at">Abstract B035: Radio-resistance of PTEN-deficient prostate tumors is enhanced by treatment-induced chemokine signaling and is associated with biochemical recurrence and&nbsp;…</a><div class="gs_gray">CWD Armstrong, JA Coulter, CW Ong, PJ Maxwell, KT Butterworth, ...</div><div class="gs_gray">Cancer Research 78 (16 Supplement), B035-B035<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Radio-resistance of PTEN-deficient prostate tumours is enhanced by treatment-induced chemokine signalling and is associated with biochemical recurrence and development of&nbsp;…</a><div class="gs_gray">C Armstrong, J Coulter, CW Ong, P Maxwell, K Butterworth, L Oksana, ...</div><div class="gs_gray">AACR Special Conference Prostate Cancer: Advances in Basic, Translational&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:buQ7SEKw-1sC" class="gsc_a_at">EP-2397: Therapeutic Radiographer follow up for prostate cancer patients</a><div class="gs_gray">S Hetherington, K Crowther, S Jain, D Mitchell, J O'Sullivan, L Shum, ...</div><div class="gs_gray">Radiotherapy and Oncology 127, S1255<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:jL-93Qbq4QoC" class="gsc_a_at">PV-0365: CASPIR Trial: Calculi as an alternative to fiducial markers for IGRT in localised prostate cancer</a><div class="gs_gray">A O'Neill, R King, K Crowther, S Osman, S Jain, AR Hounsell, ...</div><div class="gs_gray">Radiotherapy and Oncology 127, S186<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Reply to ‘Single high dose versus repeated bone-targeted radionuclide therapy’</a><div class="gs_gray">AM Denis-Bacelar, SJ Chittenden, DP Dearnaley, A Divoli, JM O’Sullivan, ...</div><div class="gs_gray">European journal of nuclear medicine and molecular imaging 45 (3), 515-517<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2ywjKiB__4kC" class="gsc_a_at">inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis</a><div class="gs_gray">KA Lee, M Dunne, C Small, PJ Kelly, O McArdle, J O’Sullivan, D Hacking, ...</div><div class="gs_gray">ACTA ONCOLOGICA 57 (7), 965-972<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Aul-kAQHnToC" class="gsc_a_at">Recognizing symptom burden in advanced prostate cancer: a global patient and caregiver survey</a><div class="gs_gray">M Schostak, WK Oh, B Tombal, A Delacruz, B Tomlinson, AV Ripley, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 40, 320-320<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Effects of concomitant medication and baseline parameters on overall survival and safety in German metastatic castration-resistant prostate cancer patient subset treated with&nbsp;…</a><div class="gs_gray">A Heidenreich, F Saad, J Cartes, S Gillessen, D Heinrich, J Graft, K Miller, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 40, 268-268<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_OXeSy2IsFwC" class="gsc_a_at">PERIPHERAL BLOOD STEM CELL (PBSC) HAPLOIDENTICAL TRANSPLANTATION VERSUS MISMATCHED UNRELATED DONOR TRANSPLANTATION: A SINGLE UK CENTRE EXPERIENCE</a><div class="gs_gray">J O'Sullivan, K Parmesar, D McLornan, DL Hugues, V Potter, M Streetly, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 631-631<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:GFxP56DSvIMC" class="gsc_a_at">PO-0970: Prostate brachytherapy; DNA damage biomarker (gH2AX) induction rate correlates with late toxicity</a><div class="gs_gray">S Osman, S Horn, D Brady, SJ McMahon, ABM Yoosuf, D Mitchell, ...</div><div class="gs_gray">Radiotherapy and Oncology 123, S535-S536<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:8xutWZnSdmoC" class="gsc_a_at">CASPIR Trial: Interim analysis of prostatic calculi as an alternative to fiducial markers for IGRT</a><div class="gs_gray">AGM O’Neill, R King, KCCA Lyons, CK McGarry, DM Mitchell, S Jain, ...</div><div class="gs_gray">Radiotherapy and Oncology 123, S1007-S1007<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Ehil0879vHcC" class="gsc_a_at">A gene expression assay to predict the risk of distant metastases in localized prostate cancer</a><div class="gs_gray">S Jain, C Lyons, J O'Sullivan, D Waugh</div><div class="gs_gray">36th European SocieTy for Radiotherapy &amp; Oncology (ESTRO) Annual Meeting<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:nZcligLrVowC" class="gsc_a_at">EP-1340: Comparing dosimetry and toxicity of 5-field IMRT versus VMAT for prostate &amp; pelvic nodal irradiation</a><div class="gs_gray">P Turner, S Jain, D Mitchell, J Harney, F Houghton, J McAleese, D Stewart, ...</div><div class="gs_gray">Radiotherapy and Oncology 123, S718-S719<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:C33y2ycGS3YC" class="gsc_a_at">Phase I/II trials of Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival.</a><div class="gs_gray">A Denis-Bacelar, S Chittenden, D Dearnaley, A Divoli, J O'Sullivan, ...</div><div class="gs_gray">European Journal of Nuclear Medicine &amp; Molecular Imaging 44 (4)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:3htObqc8RwsC" class="gsc_a_at">MP57-10 RELATIONSHIP BETWEEN QUALITY OF LIFE AND OVERALL SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN ALSYMPCA: ANALYSIS BY PRIOR DOCETAXEL SUBGROUP</a><div class="gs_gray">ND Shore, S Nilsson, O Sartor, NJ Vogelzang, RE Coleman, ...</div><div class="gs_gray">The Journal of Urology 197 (4S), e767-e767<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Enhanced radio-sensitivity of PTEN-deficient prostate tumours mediated by inhibition of intrinsic and treatment-potentiated CXC-chemokine signaling</a><div class="gs_gray">C Armstrong, J Coulter, CW Ong, P Maxwell, MLB Wilson, K Butterworth, ...</div><div class="gs_gray">European Alliance for Personalised Medicine Conference:“Personalising your&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients&nbsp;…</a><div class="gs_gray">S Zastrow, F Saad, D Heinrich, S Gillessen, J OSullivan, J Carles, K Miller, ...</div><div class="gs_gray">Oncol. Res. Treat. 40, 94-95<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy</a><div class="gs_gray">B Berge, DP Harkin, J James, JM O’Sullivan, RD Kennedy, DJ Waugh</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:u-coK7KVo8oC" class="gsc_a_at">Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)</a><div class="gs_gray">M Wirth, F Saad, D Keizman, JM O'Sullivan, J Carles, S Gillessen, ...</div><div class="gs_gray">Oncology Research and Treatment 40, 320-320<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:anf4URPfarAC" class="gsc_a_at">Bone-Seeking Radionuclide for Therapy</a><div class="gs_gray">J O’Sullivan, P Turner</div><div class="gs_gray">Bone Metastases from Prostate Cancer, 193-207<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ghEM2AJqZyQC" class="gsc_a_at">The ADRRAD Clinical Trial</a><div class="gs_gray">P Turner, S Jain, J O'Sullivan</div><div class="gs_gray">IRRS<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)</a><div class="gs_gray">F Saad, A Heidenreich, D Heinrich, D Keizman, JM O'Sullivan, J Carles, ...</div><div class="gs_gray">Annals of Oncology 27, vi254<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:DUooU5lO8OsC" class="gsc_a_at">Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)</a><div class="gs_gray">M Wirth, F Saad, D Keizman, JM O'Sullivan, J Caries, S Gillessen, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 39, 320-320<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Recognizing symptom burden in advanced prostate cancer: a global patient and caregiver survey</a><div class="gs_gray">M Schostak, WK Oh, B Tombal, A Delacruz, I Tomlinson, A Ripley, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 39, 320-320<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Results tables and figures</a><div class="gs_gray">N James, S Pirrie, A Pope, D Barton, L Andronis, I Goranitis, S Collins, ...</div><div class="gs_gray">TRAPEZE: a randomised controlled trial of the clinical effectiveness and&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2l5NCbZemmgC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">N James, S Pirrie, A Pope, D Barton, L Andronis, I Goranitis, S Collins, ...</div><div class="gs_gray">TRAPEZE: a randomised controlled trial of the clinical effectiveness and&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Patient information</a><div class="gs_gray">N James, S Pirrie, A Pope, D Barton, L Andronis, I Goranitis, S Collins, ...</div><div class="gs_gray">TRAPEZE: a randomised controlled trial of the clinical effectiveness and&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:kh2fBNsKQNwC" class="gsc_a_at">SINGLE CENTRE OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA</a><div class="gs_gray">T Rider, R Benjamin, M Streetly, A Pagliuca, S Schey, M Kazmi, K Smith, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 785-785<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:e_rmSamDkqQC" class="gsc_a_at">Does the choice of hormone therapy affect medium-term outcomes following radical external beam radiotherapy for localized prostate cancer?</a><div class="gs_gray">C Lyons, JK Blayney, DM Mitchell, JA Harney, J McAleese, L Shum, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), e16588-e16588<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-FonjvnnhkoC" class="gsc_a_at">Impact of pre-treatment neutrophil-lymphocyte ratio on outcomes in men receiving radical external beam radiotherapy for localised prostate cancer.</a><div class="gs_gray">C Lyons, S Kanabar, DM Mitchell, JA Harney, J McAleese, L Shum, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), e16604-e16604<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Preclinical radiotherapy technology, dosimetry and treatment planning</a><div class="gs_gray">K Butterworth, M Ghita, CK McGarry, S Jain, GG Hanna, JM O'Sullivan, ...</div><div class="gs_gray">Radiotherapy and Oncology 119 (Supplement 1), S238-S239<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Single UK centre outcomes of peripheral blood stem cell (PBSC) haploidentical transplantation</a><div class="gs_gray">JM O'Sullivan, A Pagliuca, M Streetly, H de Lavallade, V Potter, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 173, 15-15<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Dip1O2bNi0gC" class="gsc_a_at">More questions than answers: A systematic mixed studies literature review of the psychological impact of undergoing active surveillance for low-risk prostate cancer.</a><div class="gs_gray">E Ruane-McAteer, S Porter, J O'Sullivan, G Prue</div><div class="gs_gray">Psycho-oncology 25 (S1), 10<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Single institution, retrospective comparison of toxicity and outcome for static 5-field IMRT versus VMAT in the delivery of prostate and pelvic nodal irradiation in high-risk&nbsp;…</a><div class="gs_gray">S Jain, P Turner, G Corey, D Mitchell, DM Irvine, L Shum, DP Stewart, ...</div><div class="gs_gray">GU ASCO symposium<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:i2xiXl-TujoC" class="gsc_a_at">Single institution, retrospective comparison of toxicity and outcome for static 5-field IMRT versus VMAT in the delivery of prostate and pelvic nodal irradiation in high-risk&nbsp;…</a><div class="gs_gray">PG Turner, S Jain, G Corey, DM Mitchell, K Tumelty, D Irvine, JA Harney, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (2_suppl), 147-147<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:DyXnQzXoVgIC" class="gsc_a_at">genitourinary tumours, prostate</a><div class="gs_gray">F Saad, A Heidenreich, D Heinrich, D Keizman, JM O’Sullivan, J Carles, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:QUX0mv85b1cC" class="gsc_a_at">Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer</a><div class="gs_gray">L Andronis, I Goranitis, S Pirrie, A Pope, D Barton, S Collins, A Daunton, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:5MTHONV0fEkC" class="gsc_a_at">Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer&nbsp;…</a><div class="gs_gray">P Chakraborti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:mlAyqtXpCwEC" class="gsc_a_at">PV-0281:(ICORG 05-03): Radiotherapy in malignant spinal cord compression; The quality of life analysis</a><div class="gs_gray">K Lee, C Small, P Kelly, O McArdle, J O'Sullivan, D Hacking, M Pomeroy, ...</div><div class="gs_gray">Radiotherapy and Oncology 1 (119), S131<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:umqufdRvDiIC" class="gsc_a_at">Effects of concomitant medication and baseline parameters on overall survival and safety in German metastatic castration-resistant prostate cancer patient subset treated with&nbsp;…</a><div class="gs_gray">A Heidenreich, F Saad, J Caries, S Gillessen, D Heinrich, J Gratt, K Miller, ...</div><div class="gs_gray">Oncol. Res. Treat. 39, 268-269<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:YohjEiUPhakC" class="gsc_a_at">PV-0378: CBCT derived CTV-PTV margins for elective pelvic node irradiation of prostate cancer patients</a><div class="gs_gray">CA Lyons, RB King, CJ Ho, JY Sun, JM O'Sullivan, S Jain, AR Hounsell, ...</div><div class="gs_gray">Radiotherapy and Oncology 1 (119), S176-S177<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration resistant prostate cancer (mCRCP) patients&nbsp;…</a><div class="gs_gray">A Heidenreich, J O'Sullivan, S Gillessen, D Heinrich, J Gratt, J Levy, ...</div><div class="gs_gray">Oncol. Res. Treat. 39, 86-88<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:g3aElNc5_aQC" class="gsc_a_at">Radioisotopes reborn: radium‐223 and its role in the management of prostate cancer</a><div class="gs_gray">C Parker, J O'Sullivan, C Heath</div><div class="gs_gray">Trends in Urology &amp; Men's Health 6 (5), 40-42<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:vbGhcppDl1QC" class="gsc_a_at">SP-0368: Combined forces: Radium-223+ IMRT in the fight to cure metastatic prostate cancer</a><div class="gs_gray">JM O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology 115, S177-S178<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:BwyfMAYsbu0C" class="gsc_a_at">PO-0740: An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer</a><div class="gs_gray">C Foti, A Magli, MR Malisan, T Ceschia, M Crespi, A Prisco, G Parisi, ...</div><div class="gs_gray">Radiotherapy and Oncology 115, S366-S367<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:tuHXwOkdijsC" class="gsc_a_at">External-beam radiation therapy (EBRT) use and safety with Radium-223 dichloride (Ra) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone&nbsp;…</a><div class="gs_gray">P Stroelin, J O'Sullivan, O Sartor, C Parker, P Hoskin, A Widmark, ...</div><div class="gs_gray">Oncology Research and Treatment 38, 82-82<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:z_wVstp3MssC" class="gsc_a_at">Personalised molecular radiotherapy treatment planning in castrate-resistant prostate cancer metastatic to bone</a><div class="gs_gray">AM Denis-Bacelar, A Divoli, S Chittenden, Y Du, DP Dearnaley, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 41, S271-S271<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:VLnqNzywnoUC" class="gsc_a_at">Retrospective dosimetry in palliative molecular radiotherapy with Re-186-HEDP for bone pain in patients with castrate-resistant prostate cancer</a><div class="gs_gray">AM Denis-Bacelar, A Divoli, S Chittenden, Y Du, DP Dearnaley, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 41, S174-S175<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ye4kPcJQO24C" class="gsc_a_at">PET-CT before colorectal cancer surgery is not beneficial</a><div class="gs_gray">S Tanday</div><div class="gs_gray">The Lancet Oncology 15 (7), e256<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">From trial to practice: The Northern Ireland cancer center experience with abiraterone acetate in men with metastatic castration resistant prostate cancer.</a><div class="gs_gray">A El-Helali, P Das, S Jain, DM Mitchell, L Shum, DP Stewart, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), e16101-e16101<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Weekly bortezomib/cyclophosphamide/dexamethasone for relapsed myeloma: a retrospective review: 167</a><div class="gs_gray">M Streetly, J O'Sullivan, G Milner, C Yeomans, D Gunning, S Deppe, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PaBasH6fAo0C" class="gsc_a_at">Variation in Haemoglobin Reference Ranges and Implications for Use of Health Service Resource in the Republic of Ireland and the UK</a><div class="gs_gray">JM O’Sullivan, T McNamee, JM Harrington, IJ Perry, MR Cahill</div><div class="gs_gray">Journal of Hematology and Oncology Research 1 (1), 24-27<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Bicalutamide (150 mg) monotherapy versus LHRHa as neoadjuvant treatment in intermediate-and high-risk prostate cancer: A case matched study.</a><div class="gs_gray">DM Mitchell, C McDowell, U McGivern, G Corey, J O'Hare, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 32 (4_suppl), 226-226<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Lung Cancer Virtual Special Issue</a><div class="gs_gray">R Jena</div><div class="gs_gray">Clinical Oncology 26 (2), 65-66<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:EkHepimYqZsC" class="gsc_a_at">PO-0737: Effects of Radium-223 Dichloride on Health-Related QOL in CRPC Pts with Bone Mets from the Ph 3 ALSYMPCA Trial</a><div class="gs_gray">J O'Sullivan, C Parker, D Heinrich, D Bottomley, P Hoskin, L Franzén, ...</div><div class="gs_gray">Radiotherapy and Oncology, S35-S36<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ipzZ9siozwsC" class="gsc_a_at">EP-1327: Neo-adjuvant monotherapy with anti-androgen or LHRHa and radical prostate radiotherapy-A case matched study</a><div class="gs_gray">G Corey, DM Mitchell, C McDowell, U McGivern, J O’Hare, JM O’Sullivan</div><div class="gs_gray">Radiotherapy and Oncology, S97-S98<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:uc_IGeMz5qoC" class="gsc_a_at">PO-0968: Intercellular signalling in radiotherapy: Implications for margins, fractions, and modalities</a><div class="gs_gray">SJ McMahon, C McGarry, K Butterworth, J O'Sullivan, A Hounsell, K Prise</div><div class="gs_gray">Radiotherapy and Oncology, S133<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:0KyAp5RtaNEC" class="gsc_a_at">EP-1936: Gamma H2AX and 53BP1 foci in lymphocytes correlate with rectal dosimetry in low dose rate I125 prostate brachytherapy</a><div class="gs_gray">D Brady, S Horn, D Mitchell, K Prise, J O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology, S335<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:yB1At4FlUx8C" class="gsc_a_at">OC-0075: Investigation of the radiobiological implications of respiratory gating in vitro for non-small cell lung cancer</a><div class="gs_gray">AJ Cole, CK McGarry, SJ McMahon, KT Butterworth, BF O'Connell, ...</div><div class="gs_gray">Radiotherapy and Oncology, S28-S29<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Sensitivity of PTEN-deficient prostate carcinoma xenografts to ionizing radiation through inhibition of treatment-induced CXCL8 signaling.</a><div class="gs_gray">CWD Armstrong, JA Coulter, S Walker, RD Kennedy, KM Prise, ...</div><div class="gs_gray">MOLECULAR CANCER THERAPEUTICS 12 (11)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:70eg2SAEIzsC" class="gsc_a_at">Abstract C215: Sensitivity of PTEN-deficient prostate carcinoma xenografts to ionizing radiation through inhibition of treatment-induced CXCL8 signaling.</a><div class="gs_gray">CWD Armstrong, JA Coulter, S Walker, RD Kennedy, KM Prise, ...</div><div class="gs_gray">Molecular Cancer Therapeutics 12 (11 Supplement), C215-C215<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_xSYboBqXhAC" class="gsc_a_at">Efficacy and safety of radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases who had prior or no-prior docetaxel (D&nbsp;…</a><div class="gs_gray">F Koenig, N Vogelzang, S Helle, D Johannessen, J O'Sullivan, ...</div><div class="gs_gray">Onkologie 36<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:yD5IFk8b50cC" class="gsc_a_at">Absorbed dose distributions in patients with bone metastases from hormone refractory prostate cancer treated with Re-186 HEDP</a><div class="gs_gray">AM Bacelar, A Divoli, S Chittenden, Y Du, DP Dearnaley, JM O'Sullivan, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 40, S188-S188<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NJ774b8OgUMC" class="gsc_a_at">Alpha Particle Therapy in Metastatic Prostate Cancer</a><div class="gs_gray">J O’Sullivan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:j7_hQOaDUrUC" class="gsc_a_at">A CALL FOR A STANDARDISED MEASUREMENT OF HAEMOGLOBIN IN THE REPUBLIC OF IRELAND</a><div class="gs_gray">J O'Sullivan, T McNamee, J Harrington, I Perry, M Cahill</div><div class="gs_gray">HAEMATOLOGICA 98, 216-216<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:u9iWguZQMMsC" class="gsc_a_at">Review of bone marrow examination quality in a university teaching hospital and referring peripheral hospitals: 66</a><div class="gs_gray">J O'Sullivan, S Prendeville, T Browne, K Feeley, C Duggan, M Cahill</div><div class="gs_gray">British Journal of Haematology 161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Immunohistochemistry of multiple myeloma and impact on overall survival: 141</a><div class="gs_gray">J O'Sullivan, M Moonim, K McDonald, O Stewart, G Milner, M Kazmi, ...</div><div class="gs_gray">British Journal of Haematology 161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:9c2xU6iGI7YC" class="gsc_a_at">EP-1227: Increasing the dose inhomogeneity in the prostate PTV reduces dose delivered to the adjacent OARs</a><div class="gs_gray">R de Graaf, A Tijhuis, TM Janssen, EM Damen, C van Vliet-Vroegindeweij</div><div class="gs_gray">Radiotherapy and Oncology 106, S463-S464<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:L7CI7m0gUJcC" class="gsc_a_at">OC-0286: Radiobiological implications of respiratory motion in the treatment of lung cancer</a><div class="gs_gray">AJ Cole, CK McGarry, KT Butterworth, KM Prise, AR Hounsell, ...</div><div class="gs_gray">Radiotherapy and Oncology 106, S111<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:EYYDruWGBe4C" class="gsc_a_at">EP-1228: Advantages and limitations of multi-criteria optimization (MCO) for prostate IMRT planning.</a><div class="gs_gray">CK McGarry, R Bokrantz, JM O'Sullivan, AR Hounsell</div><div class="gs_gray">Radiotherapy and Oncology 106, S464<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WqliGbK-hY8C" class="gsc_a_at">Sensitivity of PTEN-deficient prostate carcinoma cells to ionizing radiation through inhibition of treatment-induced CXCL8 signaling.</a><div class="gs_gray">C Armstrong, J Coulter, P Maxwell, S Berlingeri, JM O'Sullivan, K Prise, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (6_suppl), 154-154<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Differential Mechanisms of Cellular Radiobiological Response Following Exposure to Intensity Modulated Radiation Fields</a><div class="gs_gray">K Butterworth, CK McGarry, C Trainor, SJ McMahon, G Schettino, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 84 (3), S672<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Assessing the consistency of bladder filling using an ultrasonic Bladderscan® device: Author response</a><div class="gs_gray">S Hynds, CK Mcgarry, DM Mitchell, S Early, L Shum, DP Stewart, ...</div><div class="gs_gray">The British Journal of Radiology 85 (1018), 1428<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:D03iK_w7-QYC" class="gsc_a_at">Radium-223 chloride impact on skeletal-related events in patients with castration-resistant prostate cancer (CRPC) with bone metastases: A phase III randomized trial (ALSYMPCA)</a><div class="gs_gray">K Miller, AO Sartor, D Heinrich, S Helle, JM O'Sullivan, SD Fossa, ...</div><div class="gs_gray">ONKOLOGIE 35, 238-239<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ldfaerwXgEUC" class="gsc_a_at">Results from a phase III randomized trial (ALSYMPCA) of radium-223 chloride, a first-in-class alpha-emitter, in patients with castration-resistant prostate cancer (CRPC) and&nbsp;…</a><div class="gs_gray">JM O'Sullivan, C Parker, A Cross, CG O'Bryan-Tear, J Garcia-Vargas, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S294-S294<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:5awf1xo2G04C" class="gsc_a_at">Neoadjuvant hormone therapy for radical prostate radiotherapy: A case-matched study comparing bicalutamide to LHRH agonist therapy.</a><div class="gs_gray">J O'Hare, U McGivern, C McDowell, DM Mitchell, G Corey, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 30 (5_suppl), 88-88<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:WbkHhVStYXYC" class="gsc_a_at">Abstract B4: Elevated expression of c-FLIP in castrate-resistant prostate cancer antagonizes response to androgen receptor-targeted therapy</a><div class="gs_gray">C McCourt, P Maxwell, R Mazzucchelli, M Salto-Tellez, J O'Sullivan, ...</div><div class="gs_gray">Cancer Research 72 (4 Supplement), B4-B4<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:LI9QrySNdTsC" class="gsc_a_at">DNA Damage Responses following Exposure to Modulated Radiation</a><div class="gs_gray">C Trainor, KT Butterworth, CK McGarry, SJ McMahon, JM O’Sullivan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:wbdj-CoPYUoC" class="gsc_a_at">PO-0848 PREDICTING ACUTE URINARY TOXICITY AFTER PROSTATE RADIOTHERAPY USING ABSOLUTE AND RELATIVE BLADDER DOSE VOLUMES</a><div class="gs_gray">D Mitchell, CK McGarry, S Hynds, S Hetherington, A Cole, L Shum, ...</div><div class="gs_gray">Radiotherapy and Oncology, S331<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:D_sINldO8mEC" class="gsc_a_at">EP-1574 MODELLING EFFECTS OF INTERCELLULAR COMMUNICATION ON CELL SURVIVAL AFTER MODULATED RADIATION EXPOSURE</a><div class="gs_gray">SJ McMahon, KT Butterworth, CK McGarry, C Trainor, JM O'Sullivan, ...</div><div class="gs_gray">Radiotherapy and Oncology, S603-S604<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:SP6oXDckpogC" class="gsc_a_at">EP-1603 IMAGE GUIDED RADIOTHERAPY USING INTRA-PROSTATIC GOLD FIDUCIAL MARKERS AND MEGAVOLTAGE ELECTRONIC PORTAL IMAGING</a><div class="gs_gray">A O'Neill, D Irvine, M Wilkinson, M Gillen, P Keane, JM O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology, S614-S615<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Men and masculinity: a comparison of men and women with colorectal cancer: Abstract ID:# 0121</a><div class="gs_gray">E McCaughan, G Prue, K Parahoo, S McIlfatrick, O McSorley, J O'Sullivan, ...</div><div class="gs_gray">Journal of Men's Health 8 (3), 228-228<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:_B80troHkn4C" class="gsc_a_at">18F-FDG PET/CT SIMULATION IN AN ALREADY PET/CT STAGED NSCLC PATIENTS. THE IMPACT ON INTER-OBSERVER VARIATION AND NORMAL TISSUE DOSE ESTIMATES.</a><div class="gs_gray">GG Hanna, KJ Carson, J Mcaleese, VP Cosgrove, RL Eakin, DP Stewart, ...</div><div class="gs_gray">JOURNAL OF THORACIC ONCOLOGY 6 (6), S814-S815<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:lgwcVrK6X84C" class="gsc_a_at">TEMPORAL CHARACTERISATION AND IN-VITRO COMPARISON OF CELL SURVIVAL FOLLOWING DELIVERY OF 3D-CONFORMAL, INTENSITY MODULATED RADIATION THERAPY (IMRT) AND VOLUMETRIC MODULATED ARC&nbsp;…</a><div class="gs_gray">C Mc Garry, K Butterworth, C Trainor, J O'Sullivan, K Prise, AR Hounsell</div><div class="gs_gray">RADIOTHERAPY AND ONCOLOGY 99, S104-S104<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:8AbLer7MMksC" class="gsc_a_at">Exploring and comparing the experience, and coping behaviour, of men and women with colorectal cancer; a qualitative longitudinal study</a><div class="gs_gray">E McCaughan, G Prue, K Parahoo, O McSorley, J O'Sullivan, H McKenna, ...</div><div class="gs_gray">Unknown Publisher<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Understanding radiotherapy and its potential for use in novel combination trials</a><div class="gs_gray">JM O’Sullivan, A Henry, J Staffurth</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Use of speed and extent of PSA response during the first three cycles of docetaxel chemotherapy in metastatic castrate-resistant prostate cancer to predict overall survival.</a><div class="gs_gray">RB Goody, DM Mitchell, J McAleese, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 29 (7_suppl), 48-48<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:geHnlv5EZngC" class="gsc_a_at">Comparison of Pre-radiotherapy PSA Nadir and Pre-radiotherapy PSA Kinetics in Men Receiving either Neo-adjuvant Bicalutamide or Luteinising Hormone Releasing Hormone Agonists&nbsp;…</a><div class="gs_gray">U McGivern, DM Mitchell, J O'Sullivan</div><div class="gs_gray">Clinical Oncology 23, 70-70<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:B3FOqHPlNUQC" class="gsc_a_at">72 speaker CURRENT STATUS ON TOTAL SKIN ELECTRON IRRADIATION</a><div class="gs_gray">S Hynds, D Irvine, R Houston, P Henry, S Stranex, J McAleer, J O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology, S27-S28<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:p2g8aNsByqUC" class="gsc_a_at">453 poster CONSEQUENCES OF NANOSCALE ENERGY DEPOSITION AROUND HEAVY ATOM NANOPARTICLES: IMPLICATIONS FOR RADIOTHERAPY</a><div class="gs_gray">S McMahon, W Hyland, M Muir, J Coulter, S Jain, K Butterworth, ...</div><div class="gs_gray">Radiotherapy and Oncology, S182<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:M05iB0D1s5AC" class="gsc_a_at">263 oral TEMPORAL CHARACTERISATION AND IN-VITRO COMPARISON OF CELL SURVIVAL FOLLOWING DELIVERY OF 3D-CONFORMAL, INTENSITY MODULATED RADIATION THERAPY (IMRT) AND VOLUMETRIC&nbsp;…</a><div class="gs_gray">C Mc Garry, K Butterworth, C Trainor, J O'Sullivan, K Prise, AR Hounsell</div><div class="gs_gray">Radiotherapy and Oncology, S104<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:lSLTfruPkqcC" class="gsc_a_at">Preliminary results of a randomised controlled trial to evaluate the efficacy of a dietary and physical activity intervention in prostate cancer patients receiving androgen&nbsp;…</a><div class="gs_gray">F Haseen, RF O'Neill, LJ Murray, JM O'Sullivan, MM Cantwell</div><div class="gs_gray">Proceedings of the Nutrition Society 70 (OCE1)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:evX43VCCuoAC" class="gsc_a_at">The Lack of a Bystander Response Induced by Photon Irradiation in Chondrosarcoma Cells</a><div class="gs_gray">M Wakatsuki, N Magpayo, KD Held</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 78 (3), S628<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:08ZZubdj9fEC" class="gsc_a_at">Out-of-field Cell Survival and Radiation Induced Bystander Responses following Exposure to Intensity Modulated Radiation Fields</a><div class="gs_gray">K Prise, KT Butterworth, CK McGarry, C Trainor, JM O'Sullivan, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 78 (3), S628<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:KxtntwgDAa4C" class="gsc_a_at">The Impact on PTVs and Normal Lung Dose of Using 18F-FDF PET/CT Simulation on an Already PET/CT Staged Cohort of NSCLC Patients</a><div class="gs_gray">A Hounsell, GG Hanna, KJ Carson, J McAleese, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 78 (3), S523-S524<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:43bX7VzcjpAC" class="gsc_a_at">UNINTENDED CARDIAC IRRADIATION DURING LEFT SIDED BREAST CANCER RADIOTHERAPY</a><div class="gs_gray">K McKenna, R Goody, J O'Hare, L Dearey, J Robinson, P Bell, J Clarke, ...</div><div class="gs_gray">RADIOTHERAPY AND ONCOLOGY 96, S252-S253<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:zCSUwVk65WsC" class="gsc_a_at">CONVENTIONAL 3D STAGING PET/CT IN CT SIMULATION FOR LUNG CANCER: IMPACT OF RIGID AND DEFORMABLE TARGET VOLUME ALIGNMENTS FOR RADIOTHERAPY TREATMENT PLANNING</a><div class="gs_gray">G Hanna, J de Koster, K Carson, J O'Sullivan, AR Hounsell, S Senan</div><div class="gs_gray">RADIOTHERAPY AND ONCOLOGY 96, S340-S340<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:jgBuDB5drN8C" class="gsc_a_at">GOLD NANOPARTICLES RADIOSENSITISE CELLS AT CLINICALLY RELEVANT MEGAVOLTAGE X-RAY ENERGIES.</a><div class="gs_gray">S Jain, J Coulter, K Butterworth, F Currell, K Prise, AR Hounsell, ...</div><div class="gs_gray">Radiotherapy and Oncology 96 (Supplement 1), S26-S27<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ubry08Y2EpUC" class="gsc_a_at">STUDIES OF SPATIALLY MODULATED 6MV LINEAR ACCELERATOR BEAMS IN NORMAL AND TUMOUR CELLS</a><div class="gs_gray">C Mc Garry, K Butterworth, C Trainor, J O'Sullivan, K Prise, AR Hounsell</div><div class="gs_gray">RADIOTHERAPY AND ONCOLOGY 96, S610-S610<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ZHo1McVdvXMC" class="gsc_a_at">A phase I study of combined docetaxel and repeated high activity rhenium-186-HEDP in castration-resistant prostate cancer metastatic to bone (the TAXIUM trial).</a><div class="gs_gray">JM van Dodewaard-de Jong, H Bloemendal, JM de Klerk, ...</div><div class="gs_gray">Journal of Clinical Oncology 28 (15_suppl), 4688-4688<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review</a><div class="gs_gray">F Haseen, MM Cantwell, JM O’Sullivan, LJ Murray</div><div class="gs_gray">Alternative Medicine Review 15 (1), 91-92<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:eGYfIraVYiQC" class="gsc_a_at">Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro</a><div class="gs_gray">M Prencipe, P Fitzpatrick, S Gorman, M Tosetto, R Klinger, F Furlong, ...</div><div class="gs_gray">British Journal of Cancer 102 (2), 456<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Abstract A78: Role of PTEN and ionizing radiation in underpinning differential activation of interleukin‐8 in prostate cancer cells</a><div class="gs_gray">S Berlingeri, R Gallagher, P Maxwell, J O'Sullivan, D Waugh</div><div class="gs_gray">Molecular Cancer Therapeutics 8 (12 Supplement), A78-A78<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Target Volume Definition with 18F-FDG PET-CT in the Radiotherapy Treatment Planning Process in Non–small Cell Lung Cancer: Who Should Outline and What?</a><div class="gs_gray">GG Hanna, KJ Carson, T Lynch, J McAleese, VP Cosgrove, RL Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 75 (3), S474-S475<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Repopulation Kinetics and the Linear‐Quadratic Model</a><div class="gs_gray">SFC O’Rourke, H McAneney, C Starrett, JM O’Sullivan</div><div class="gs_gray">AIP Conference Proceedings 1148 (1), 209-213<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:35N4QoGY0k4C" class="gsc_a_at">Standardization of Scanning for [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography</a><div class="gs_gray">GG Hanna, J McAleese, TB Lynch, JM O'Sullivan</div><div class="gs_gray">Journal of Clinical Oncology 27 (5), 831-832<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:PVgj2kMGcgYC" class="gsc_a_at">TWO YEARS EXPERIENCE WITH INTERNATIONAL HANDS-ON COURSES FOR RT PROFESSIONALS</a><div class="gs_gray">J Scheurleer, I Bruinvis, E Lamers, B Mijnheer</div><div class="gs_gray">Radiotherapy and Oncology, S158<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:vRqMK49ujn8C" class="gsc_a_at">PET-CT for GTV Definition Reduces Inter-observer Variation in Non-small Cell Lung cancer</a><div class="gs_gray">G Hanna, KJ Carson, J McAleese, VP Cosgrove, DP Stewart, RL Eakin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">PRELIMINARY INVESTIGATIONS INTO RADIOBIOLOGICAL EFFECTS FROM INTENSITY-MODULATED RADIATION FIELDS</a><div class="gs_gray">C McGarry, K Butterworth, K Prise, J O'Sullivan, AR Hounsell</div><div class="gs_gray">Radiotherapy and Oncology, S245<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:b0M2c_1WBrUC" class="gsc_a_at">BREAST AND SUPRA-CLAVICULAR RADIOTHERAPY SET-UP: A PROSPECTIVE AUDIT OF PRACTICE</a><div class="gs_gray">A O'Neill, M Dunn, L Archer, K Brown, B Simpson, J Robinson, D Irvine, ...</div><div class="gs_gray">Radiotherapy and Oncology, S226-S227<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:EUQCXRtRnyEC" class="gsc_a_at">THE TRANSITION FROM THERAPY RADIOGRAPHER TO CLINICAL RESEARCH RADIOGRAPHER</a><div class="gs_gray">S Early, J O'Sullivan, S Hynds</div><div class="gs_gray">Radiotherapy and Oncology, S158<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:dfsIfKJdRG4C" class="gsc_a_at">An Observational Study Assessing Bladder Volume Consistency during 3D Conformal Prostate Radiotherapy using an Ultrasonic Bladderscan Device</a><div class="gs_gray">S Hynds, D Mitchell, C McGarry, S Early, L Shum, D Stewart, J O'Sullivan</div><div class="gs_gray">Clinical Oncology 21, 269-269<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Development of New Radiobiological Models for Evaluating Intensity-modulated Radiation Fields</a><div class="gs_gray">C McGarry, K Butterworth, A Hounsell, K Prise, J O'Sullivan</div><div class="gs_gray">Clinical Oncology 21, 246-247<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:RGFaLdJalmkC" class="gsc_a_at">Failure to Achieve PSA Level≤ 1 ng/ml Following Neo-adjuvant LHRHa Therapy Predicts for a Lower Rate Biochemical Control and Lower Overall Survival in Localized Prostate&nbsp;…</a><div class="gs_gray">DM Mitchell, J McAleese, RM Park, DP Stewart, S Stranex, R Eakin, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 69 (3), S320-S321<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:SIv7DqKytYAC" class="gsc_a_at">Failure to achieve PSA level less than or equal to 1 ng/ml following neo-adjuvant LHRHa therapy predicts for a lower rate of biochemical control and lower overall survival in&nbsp;…</a><div class="gs_gray">DM Mitchell, J McAleese, RM Park, DR Stewart, S Stranex, R Eakin, ...</div><div class="gs_gray">EJC SUPPLEMENTS 5 (4), 292-292<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:YlPif8NxrbYC" class="gsc_a_at">Strategies for Pain Control</a><div class="gs_gray">J O'Sullivan</div><div class="gs_gray">Prostate Cancer (Therapeutic Strategies), 1-18<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Strategies for the Implementation of Chemotherapy and Radiotherapy for Metastatic Prostate Cancer</a><div class="gs_gray">J O'Sullivan</div><div class="gs_gray">Metastasis of Prostate Cancer, 1-20<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:dshw04ExmUIC" class="gsc_a_at">4044 POSTER Failure to achieve PSA level less than or equal to 1 ng/ml following neo-adjuvant LHRHa therapy predicts for a lower rate of biochemical control and lower overall&nbsp;…</a><div class="gs_gray">DM Mitchell, J McAleese, RM Park, DP Stewart, S Stranex, R Eakin, ...</div><div class="gs_gray">EJC Supplements 4 (5), 292<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Does dexamethasone work in androgen-independent prostate cancer (AIPC) by modulation of interleukin-8?</a><div class="gs_gray">P Scullin, A Seaton, M McDonnell, C Purcell, D Stewart, D O'Rourke, ...</div><div class="gs_gray">Bju International 100, 38-38<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">An effective protocol used in the administration of oral contrast given to patients prior to a PET/CT scan</a><div class="gs_gray">S Mundon-Hooper, LM Wilson, JM O'Sullivan, SE McEvoy, JA Lucey, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33, S389-S389<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Early metabolic change induced by neoadjuvant chemoradiotherapy, as measured by FDG PET/CT in patients with adenocarcinoma of the oesophagus and its correlation with the&nbsp;…</a><div class="gs_gray">J Lucey, C Gillham, L Wilson, AM MacArtain, J O'Sullivan, V Malik, ...</div><div class="gs_gray">Journal of Nuclear Medicine 47 (suppl 1), 229P-229P<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Bone marrow tolerance to high activities of Rhenium 186 HEDP</a><div class="gs_gray">V McCready, J O'Sullivan, A Norman, G Flux, J Treleaven, D Dearnaley</div><div class="gs_gray">Journal of Nuclear Medicine 47 (suppl 1), 487P-487P<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:5ugPr518TE4C" class="gsc_a_at">Clinical impact of a new device-eXsight (R) Macular Irradiation System</a><div class="gs_gray">S Hynds, AR Hounsell, MWD Grattan, U Daly, F Gibbs, J O'Sullivan</div><div class="gs_gray">Radiotherapy and Oncology 81, S469-S470<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:LPZeul_q3PIC" class="gsc_a_at">High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory&nbsp;…</a><div class="gs_gray">JM O'Sullivan, AR Norman, VR McCready, G Flux, G Cook, B Johnson, ...</div><div class="gs_gray">Journal of Clinical Oncology 22 (14_suppl), 4562-4562<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Symptom control in urological malignancy</a><div class="gs_gray">J O'Sullivan</div><div class="gs_gray">Surgical Pallaitive Care, 1-20<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Tiz5es2fbqcC" class="gsc_a_at">The optimum method to determine the maximum tolerated activity for high activity Re186HEDP therapy with peripheral blood stem cell support for skeletal metastases from prostate&nbsp;…</a><div class="gs_gray">VR McCready, J O'Sullivan, A Norman, J Treleaven, D Dearnaley</div><div class="gs_gray">European Journal of Nuclear Medicine and Molecular Imaging 31, S480-S481<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Cumulative contents</a><div class="gs_gray">EJ Adams, DJ Convery, VP Cosgrove, HA McNair, JN Staffurth, ...</div><div class="gs_gray">Radiotherapy and Oncology 73, 403-413<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Cited in: Chemical Abstracts, Excerpta Medica (EMBASE), Current Contents (Clinical Medicine; Life Sciences), Index Medicus (MEDLINE), Current Awareness in Biological Sciences&nbsp;…</a><div class="gs_gray">R Suzuki, K Nosaki, T Seto, M Shimokawa, T Takahashi, S Sanduleanu, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:sSrBHYA8nusC" class="gsc_a_at">14. Response to high activity (5.0 GBq) 186Re-HEDP therapy in progressive prostate cancer metastatic to bone</a><div class="gs_gray">VR McCready, JM O'Sullivan, AR Norman, G Cook, J Treleaven, G Flux, ...</div><div class="gs_gray">Nuclear Medicine Communications 24 (3), 326<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:K3LRdlH-MEoC" class="gsc_a_at">888 Cranial nerve palsies in metastatic prostate caner-results of base of skull radiotherapy</a><div class="gs_gray">JM O'Sullivan, AR Norman, H McNair, DP Dearnaley</div><div class="gs_gray">EJC Supplements 5 (1), S267<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:rO6llkc54NcC" class="gsc_a_at">Comparison of PSA measurements and scintigraphy in patients with skeletal metastases from carcinoma of the prostate treated with high activities of Re 186 HEDP.</a><div class="gs_gray">VR McCready, J O'Sullivan, DP Dearnaley, J Treleaven, G Cook</div><div class="gs_gray">The Journal of Nuclear Medicine 44, 412P-413P<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:fPk4N6BV_jEC" class="gsc_a_at">A high activity rhenium-186 HEDP with peripheral blood stem cell support phase I study in hormone refractory prostate cancer patients with skeletal metastases [Final Programme&nbsp;…</a><div class="gs_gray">VR McCready, JM O'Sullivan, DP Dearnaley, AR Norman, J Treleaven, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:t6usbXjVLHcC" class="gsc_a_at">Factors Associated with Bleomycin Lung Toxicity in Germ Cell Tumour Patients Treated at the Royal Marsden Hospital Between 1982 and 1999</a><div class="gs_gray">JM O’Sullivan, AR Norman, J Nicholls, RA Huddart, DP Dearnaley, ...</div><div class="gs_gray">Germ Cell Tumours V, 217-218<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:f2IySw72cVMC" class="gsc_a_at">Autologous peripheral blood stem cell rescue permits administration of high activities of rhenium-186 HEDP in progressive hormone refractory prostate cancer metastatic to bone</a><div class="gs_gray">J O'Sullivan, J Treleaven, V McCready, A Norman, A Horwich, R Huddart, ...</div><div class="gs_gray">Bone Marrow Transplantation 29, S44-S44<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Unexpected hematological tolerance to high activity Re-186 HEDP therapy for skeletal metastases in prostate carcinoma.</a><div class="gs_gray">VR McCready, J O'Sullivan, A Norman, DP Dearnaley, JG Treleaven, ...</div><div class="gs_gray">JOURNAL OF NUCLEAR MEDICINE 42 (5), 313P-313P<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:UxriW0iASnsC" class="gsc_a_at">High activity rhenium-186 HEDP with peripheral blood stem cell support-a novel approach to hormone refractory prostate cancer metastatic to bone</a><div class="gs_gray">JM O'Sullivan, VR McCready, J Treleaven, AR Norman, G Flux, G Cook, ...</div><div class="gs_gray">European Journal of Cancer 37, S21-S21<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Mojj43d5GZwC" class="gsc_a_at">High Throughput Screening: The Discovery of Bioactive Substances Edited by JP Devlin (AART International, Inc. New Milford, CT). Marcel Dekker, Inc., New York. 1997. xxiv+ 673&nbsp;…</a><div class="gs_gray">J O'Sullivan</div><div class="gs_gray">Journal of Natural Products 61 (1), 173-174<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Xz60mAmATU4C" class="gsc_a_at">Particulate contamination control in high-purity water for the semiconductor industry</a><div class="gs_gray">D Capitanio, P Connor, J O'Sullivan</div><div class="gs_gray">Ultrapure Water 10 (8), 36-38<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:AYInfyleIOsC" class="gsc_a_at">ELECTRONIC POSTER: PHYSICS TRACK: TREATMENT PLAN OPTIMISATION</a><div class="gs_gray">CK McGarry, R Bokrantz, JM O'Sullivan, AR Hounsell</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Therapeutic strategies for pain</a><div class="gs_gray">C Purcell, J O’Sullivan</div><div class="gs_gray">Therapeutic Strategies, 261<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:KaMxkj08jr0C" class="gsc_a_at">Oncology &amp; Haematology</a><div class="gs_gray">JM O’Sullivan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Search Site</a><div class="gs_gray">JM O’Sullivan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Review and Meta-analyses</a><div class="gs_gray">T Mathes, D Pieper, SL Antoine, M Eikermann, DH Brewster, J Lang, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Absorbed dose distributions in patients with bone metastases from hormone refractory prostate cancer treated with Re-186 HEDP</a><div class="gs_gray">AM Denis Bacelar, DP Dearnaley, A Divoli, S Chittenden, Y Du, GD Flux, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:IRz6iEL74y4C" class="gsc_a_at">Country: Ireland Group: The All-Ireland Clinical Oncology Research Group (ICORG)</a><div class="gs_gray">J O’Sullivan, A Hill</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Blood biomarkers of exposure to ionising radiation</a><div class="gs_gray">D Brady, J O’Sullivan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ojU5mu4AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ojU5mu4AAAAJ:NaGl4SEjCO4C" class="gsc_a_at">R. Huddart, D. Dearnaley (London, UK) Background: Autologous peripheral blood stem cell rescue was used in patients with progressive hormone refractory prostate cancer&nbsp;…</a><div class="gs_gray">J O'Sullivan, J Treleaven, V McCready, A Norman, A Horwich</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–435</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>